| 5.8 |
34.7 |
GO:0009051 |
pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 4.9 |
19.6 |
GO:0010900 |
negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
| 4.9 |
9.7 |
GO:0019520 |
aldonic acid metabolic process(GO:0019520) D-gluconate metabolic process(GO:0019521) |
| 4.6 |
23.0 |
GO:0060741 |
prostate gland stromal morphogenesis(GO:0060741) |
| 4.1 |
20.3 |
GO:0009439 |
cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
| 3.9 |
11.7 |
GO:1903697 |
negative regulation of microvillus assembly(GO:1903697) |
| 3.7 |
11.1 |
GO:0050760 |
negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
| 3.6 |
10.8 |
GO:2000830 |
vacuolar phosphate transport(GO:0007037) positive regulation of mitotic cell cycle DNA replication(GO:1903465) positive regulation of parathyroid hormone secretion(GO:2000830) |
| 3.6 |
10.8 |
GO:0061181 |
regulation of chondrocyte development(GO:0061181) |
| 3.6 |
14.3 |
GO:0000379 |
tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 3.3 |
10.0 |
GO:0006059 |
hexitol metabolic process(GO:0006059) |
| 3.3 |
13.2 |
GO:0021966 |
corticospinal neuron axon guidance(GO:0021966) |
| 3.2 |
15.9 |
GO:0060160 |
negative regulation of dopamine receptor signaling pathway(GO:0060160) |
| 3.1 |
12.3 |
GO:0045013 |
carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
| 3.0 |
27.4 |
GO:0031444 |
slow-twitch skeletal muscle fiber contraction(GO:0031444) |
| 3.0 |
12.2 |
GO:0019056 |
modulation by virus of host transcription(GO:0019056) positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) modulation by symbiont of host transcription(GO:0052026) |
| 3.0 |
18.3 |
GO:0015878 |
biotin transport(GO:0015878) pantothenate transmembrane transport(GO:0015887) |
| 3.0 |
3.0 |
GO:0034128 |
negative regulation of MyD88-independent toll-like receptor signaling pathway(GO:0034128) |
| 3.0 |
15.0 |
GO:0006546 |
glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 2.9 |
8.8 |
GO:0043181 |
vacuolar sequestering(GO:0043181) |
| 2.9 |
20.5 |
GO:0045079 |
negative regulation of chemokine biosynthetic process(GO:0045079) |
| 2.9 |
17.4 |
GO:0070981 |
L-asparagine biosynthetic process(GO:0070981) L-asparagine metabolic process(GO:0070982) |
| 2.9 |
8.6 |
GO:1903225 |
negative regulation of endodermal cell differentiation(GO:1903225) |
| 2.9 |
8.6 |
GO:0070902 |
mitochondrial tRNA pseudouridine synthesis(GO:0070902) |
| 2.8 |
8.5 |
GO:0060278 |
regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
| 2.8 |
13.9 |
GO:0090579 |
transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
| 2.8 |
8.3 |
GO:0017186 |
peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
| 2.8 |
8.3 |
GO:1903461 |
Okazaki fragment processing involved in mitotic DNA replication(GO:1903461) |
| 2.7 |
16.3 |
GO:1903412 |
response to bile acid(GO:1903412) |
| 2.6 |
20.9 |
GO:0046618 |
drug export(GO:0046618) |
| 2.6 |
10.4 |
GO:0015772 |
disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 2.6 |
10.3 |
GO:0060032 |
notochord regression(GO:0060032) |
| 2.5 |
5.1 |
GO:0050968 |
detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
| 2.5 |
10.1 |
GO:0072287 |
metanephric distal tubule morphogenesis(GO:0072287) |
| 2.5 |
2.5 |
GO:0010609 |
mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) |
| 2.5 |
7.5 |
GO:0014707 |
branchiomeric skeletal muscle development(GO:0014707) |
| 2.5 |
9.8 |
GO:0006272 |
leading strand elongation(GO:0006272) |
| 2.4 |
12.2 |
GO:0015862 |
uridine transport(GO:0015862) |
| 2.4 |
7.3 |
GO:0015920 |
lipopolysaccharide transport(GO:0015920) |
| 2.4 |
21.8 |
GO:0006021 |
inositol biosynthetic process(GO:0006021) |
| 2.4 |
12.1 |
GO:0019242 |
methylglyoxal biosynthetic process(GO:0019242) |
| 2.4 |
9.6 |
GO:0042369 |
vitamin D catabolic process(GO:0042369) |
| 2.4 |
26.3 |
GO:0032226 |
positive regulation of synaptic transmission, dopaminergic(GO:0032226) |
| 2.4 |
7.1 |
GO:0031662 |
regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031660) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031662) response to DDT(GO:0046680) histone H3-S10 phosphorylation involved in chromosome condensation(GO:2000775) |
| 2.4 |
19.0 |
GO:2000857 |
positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
| 2.3 |
25.7 |
GO:0030259 |
lipid glycosylation(GO:0030259) |
| 2.3 |
11.6 |
GO:0061030 |
epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
| 2.3 |
16.2 |
GO:0046208 |
spermine catabolic process(GO:0046208) |
| 2.3 |
6.9 |
GO:0046081 |
dUTP metabolic process(GO:0046080) dUTP catabolic process(GO:0046081) |
| 2.3 |
4.6 |
GO:0007386 |
compartment pattern specification(GO:0007386) |
| 2.2 |
6.7 |
GO:1902723 |
negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
| 2.2 |
8.9 |
GO:1904482 |
response to tetrahydrofolate(GO:1904481) cellular response to tetrahydrofolate(GO:1904482) |
| 2.2 |
11.2 |
GO:0060301 |
vestibulocochlear nerve structural organization(GO:0021649) positive regulation of cytokine activity(GO:0060301) ganglion morphogenesis(GO:0061552) VEGF-activated neuropilin signaling pathway involved in axon guidance(GO:1902378) dorsal root ganglion morphogenesis(GO:1904835) otic placode development(GO:1905040) |
| 2.2 |
8.9 |
GO:0046271 |
phenylpropanoid catabolic process(GO:0046271) |
| 2.2 |
6.6 |
GO:0071423 |
thiosulfate transport(GO:0015709) oxaloacetate transport(GO:0015729) malate transport(GO:0015743) malate transmembrane transport(GO:0071423) oxaloacetate(2-) transmembrane transport(GO:1902356) |
| 2.2 |
6.6 |
GO:1901069 |
guanosine-containing compound catabolic process(GO:1901069) |
| 2.2 |
13.0 |
GO:0035407 |
histone H3-T11 phosphorylation(GO:0035407) |
| 2.1 |
12.8 |
GO:1902445 |
regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
| 2.1 |
4.2 |
GO:0016185 |
synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
| 2.1 |
6.3 |
GO:0090427 |
activation of meiosis(GO:0090427) |
| 2.1 |
16.8 |
GO:0070649 |
polar body extrusion after meiotic divisions(GO:0040038) formin-nucleated actin cable assembly(GO:0070649) |
| 2.1 |
12.5 |
GO:1902462 |
regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 2.1 |
12.4 |
GO:0006001 |
fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
| 2.1 |
8.3 |
GO:1904020 |
regulation of G-protein coupled receptor internalization(GO:1904020) |
| 2.0 |
6.1 |
GO:0060265 |
positive regulation of respiratory burst involved in inflammatory response(GO:0060265) |
| 2.0 |
8.1 |
GO:0002432 |
granuloma formation(GO:0002432) |
| 2.0 |
4.0 |
GO:0072021 |
ascending thin limb development(GO:0072021) metanephric ascending thin limb development(GO:0072218) |
| 2.0 |
8.0 |
GO:0061743 |
motor learning(GO:0061743) |
| 2.0 |
23.8 |
GO:0032286 |
central nervous system myelin maintenance(GO:0032286) |
| 2.0 |
4.0 |
GO:0019322 |
pentose biosynthetic process(GO:0019322) |
| 2.0 |
5.9 |
GO:0002416 |
IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
| 2.0 |
5.9 |
GO:0042699 |
follicle-stimulating hormone signaling pathway(GO:0042699) |
| 2.0 |
5.9 |
GO:0060827 |
regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060827) negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060829) |
| 2.0 |
2.0 |
GO:1901420 |
regulation of vitamin D receptor signaling pathway(GO:0070562) negative regulation of vitamin D receptor signaling pathway(GO:0070563) regulation of response to alcohol(GO:1901419) negative regulation of response to alcohol(GO:1901420) |
| 1.9 |
23.4 |
GO:0023041 |
neuronal signal transduction(GO:0023041) |
| 1.9 |
5.8 |
GO:0031548 |
regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031548) |
| 1.9 |
5.8 |
GO:0072061 |
inner medullary collecting duct development(GO:0072061) |
| 1.9 |
3.8 |
GO:0035696 |
monocyte extravasation(GO:0035696) regulation of monocyte extravasation(GO:2000437) |
| 1.9 |
11.4 |
GO:0007354 |
zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
| 1.9 |
5.7 |
GO:0001994 |
norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
| 1.8 |
51.7 |
GO:0031915 |
positive regulation of synaptic plasticity(GO:0031915) |
| 1.8 |
11.0 |
GO:0035992 |
tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
| 1.8 |
1.8 |
GO:1901662 |
phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
| 1.8 |
18.0 |
GO:0009111 |
vitamin catabolic process(GO:0009111) |
| 1.8 |
1.8 |
GO:0021526 |
medial motor column neuron differentiation(GO:0021526) |
| 1.8 |
18.0 |
GO:0097039 |
protein linear polyubiquitination(GO:0097039) |
| 1.8 |
7.2 |
GO:0071393 |
cellular response to progesterone stimulus(GO:0071393) |
| 1.8 |
16.1 |
GO:0035865 |
cellular response to potassium ion(GO:0035865) |
| 1.8 |
25.0 |
GO:0007144 |
female meiosis I(GO:0007144) |
| 1.8 |
1.8 |
GO:0044333 |
Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
| 1.8 |
7.1 |
GO:0044314 |
protein K27-linked ubiquitination(GO:0044314) |
| 1.8 |
1.8 |
GO:0098905 |
regulation of bundle of His cell action potential(GO:0098905) |
| 1.8 |
7.1 |
GO:1904106 |
protein localization to microvillus(GO:1904106) |
| 1.8 |
1.8 |
GO:0072014 |
proximal tubule development(GO:0072014) |
| 1.8 |
5.3 |
GO:0100009 |
regulation of fever generation by regulation of prostaglandin secretion(GO:0071810) positive regulation of fever generation by positive regulation of prostaglandin secretion(GO:0071812) positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling(GO:0071848) regulation of fever generation by prostaglandin secretion(GO:0100009) |
| 1.8 |
10.5 |
GO:1904048 |
regulation of spontaneous neurotransmitter secretion(GO:1904048) |
| 1.7 |
1.7 |
GO:0046543 |
development of secondary sexual characteristics(GO:0045136) development of secondary female sexual characteristics(GO:0046543) |
| 1.7 |
6.9 |
GO:0061760 |
antifungal innate immune response(GO:0061760) |
| 1.7 |
5.1 |
GO:0033634 |
positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
| 1.7 |
17.1 |
GO:0070560 |
protein secretion by platelet(GO:0070560) |
| 1.7 |
13.6 |
GO:1900264 |
regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 1.7 |
5.1 |
GO:0071629 |
cytoplasm-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071629) |
| 1.7 |
5.1 |
GO:0021938 |
ventral midline development(GO:0007418) smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
| 1.7 |
3.4 |
GO:2000542 |
negative regulation of gastrulation(GO:2000542) |
| 1.7 |
5.0 |
GO:0052151 |
positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation of apoptotic process by virus(GO:0060139) |
| 1.7 |
1.7 |
GO:0060214 |
endocardium formation(GO:0060214) |
| 1.7 |
5.0 |
GO:0090108 |
positive regulation of high-density lipoprotein particle assembly(GO:0090108) positive regulation of secretion of lysosomal enzymes(GO:0090340) |
| 1.6 |
8.2 |
GO:0015722 |
canalicular bile acid transport(GO:0015722) |
| 1.6 |
4.9 |
GO:0007506 |
gonadal mesoderm development(GO:0007506) |
| 1.6 |
4.9 |
GO:2000588 |
positive regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000588) |
| 1.6 |
8.2 |
GO:1902228 |
mammary gland fat development(GO:0060611) positive regulation of macrophage colony-stimulating factor signaling pathway(GO:1902228) positive regulation of response to macrophage colony-stimulating factor(GO:1903971) positive regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903974) positive regulation of microglial cell migration(GO:1904141) |
| 1.6 |
1.6 |
GO:0017055 |
negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
| 1.6 |
8.2 |
GO:2000051 |
negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
| 1.6 |
8.2 |
GO:0032218 |
riboflavin transport(GO:0032218) |
| 1.6 |
9.8 |
GO:0051958 |
methotrexate transport(GO:0051958) |
| 1.6 |
3.2 |
GO:0098881 |
exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
| 1.6 |
6.5 |
GO:0035565 |
regulation of pronephros size(GO:0035565) |
| 1.6 |
25.7 |
GO:0051599 |
response to hydrostatic pressure(GO:0051599) |
| 1.6 |
22.4 |
GO:0048387 |
negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 1.6 |
11.2 |
GO:0032417 |
positive regulation of sodium:proton antiporter activity(GO:0032417) |
| 1.6 |
4.8 |
GO:1904975 |
response to bleomycin(GO:1904975) cellular response to bleomycin(GO:1904976) |
| 1.6 |
4.8 |
GO:0046356 |
acetyl-CoA catabolic process(GO:0046356) |
| 1.6 |
4.7 |
GO:0070904 |
L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
| 1.6 |
4.7 |
GO:0009443 |
pyridoxal 5'-phosphate salvage(GO:0009443) |
| 1.6 |
4.7 |
GO:1902463 |
protein localization to cell leading edge(GO:1902463) |
| 1.6 |
4.7 |
GO:0019243 |
methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
| 1.6 |
7.8 |
GO:0097089 |
methyl-branched fatty acid metabolic process(GO:0097089) |
| 1.5 |
6.2 |
GO:2000230 |
response to metformin(GO:1901558) negative regulation of pancreatic stellate cell proliferation(GO:2000230) |
| 1.5 |
13.8 |
GO:0000727 |
double-strand break repair via break-induced replication(GO:0000727) |
| 1.5 |
4.5 |
GO:0031427 |
response to methotrexate(GO:0031427) |
| 1.5 |
4.5 |
GO:1903251 |
multi-ciliated epithelial cell differentiation(GO:1903251) |
| 1.5 |
1.5 |
GO:0044849 |
estrous cycle(GO:0044849) |
| 1.5 |
4.4 |
GO:2001113 |
negative regulation of hepatocyte growth factor receptor signaling pathway(GO:1902203) regulation of cellular response to hepatocyte growth factor stimulus(GO:2001112) negative regulation of cellular response to hepatocyte growth factor stimulus(GO:2001113) |
| 1.5 |
19.0 |
GO:0019375 |
galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 1.5 |
2.9 |
GO:0070166 |
enamel mineralization(GO:0070166) |
| 1.4 |
5.8 |
GO:2000110 |
negative regulation of macrophage apoptotic process(GO:2000110) |
| 1.4 |
8.6 |
GO:1902499 |
positive regulation of protein autoubiquitination(GO:1902499) |
| 1.4 |
5.8 |
GO:0006850 |
mitochondrial pyruvate transport(GO:0006850) mitochondrial pyruvate transmembrane transport(GO:1902361) |
| 1.4 |
1.4 |
GO:0071500 |
cellular response to nitrosative stress(GO:0071500) |
| 1.4 |
10.0 |
GO:0060356 |
leucine import(GO:0060356) |
| 1.4 |
5.7 |
GO:0035544 |
negative regulation of SNARE complex assembly(GO:0035544) |
| 1.4 |
2.8 |
GO:0006550 |
isoleucine catabolic process(GO:0006550) |
| 1.4 |
2.8 |
GO:0034085 |
establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 1.4 |
15.5 |
GO:0018103 |
protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 1.4 |
5.6 |
GO:0006535 |
cysteine biosynthetic process from serine(GO:0006535) |
| 1.4 |
5.6 |
GO:0001560 |
regulation of cell growth by extracellular stimulus(GO:0001560) |
| 1.4 |
4.2 |
GO:0038163 |
thrombopoietin-mediated signaling pathway(GO:0038163) |
| 1.4 |
4.2 |
GO:0071139 |
resolution of recombination intermediates(GO:0071139) resolution of mitotic recombination intermediates(GO:0071140) |
| 1.4 |
5.5 |
GO:0033567 |
DNA replication, Okazaki fragment processing(GO:0033567) |
| 1.4 |
4.2 |
GO:0042660 |
positive regulation of cell fate specification(GO:0042660) |
| 1.4 |
4.1 |
GO:0042727 |
flavin-containing compound biosynthetic process(GO:0042727) |
| 1.4 |
8.3 |
GO:0043988 |
histone H3-S28 phosphorylation(GO:0043988) |
| 1.4 |
9.6 |
GO:0000821 |
regulation of arginine metabolic process(GO:0000821) |
| 1.4 |
1.4 |
GO:0072098 |
intermediate mesoderm development(GO:0048389) pattern specification involved in mesonephros development(GO:0061227) anterior/posterior pattern specification involved in kidney development(GO:0072098) |
| 1.4 |
2.7 |
GO:0005997 |
xylulose metabolic process(GO:0005997) |
| 1.4 |
5.4 |
GO:1905045 |
Schwann cell proliferation involved in axon regeneration(GO:0014011) negative regulation of Schwann cell migration(GO:1900148) regulation of Schwann cell proliferation involved in axon regeneration(GO:1905044) negative regulation of Schwann cell proliferation involved in axon regeneration(GO:1905045) |
| 1.4 |
5.4 |
GO:1904844 |
response to L-glutamine(GO:1904844) cellular response to L-glutamine(GO:1904845) |
| 1.4 |
2.7 |
GO:0090244 |
Wnt signaling pathway involved in somitogenesis(GO:0090244) |
| 1.4 |
9.5 |
GO:0046104 |
thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
| 1.4 |
6.8 |
GO:1903400 |
L-arginine transmembrane transport(GO:1903400) |
| 1.4 |
9.5 |
GO:0042262 |
DNA protection(GO:0042262) |
| 1.3 |
13.5 |
GO:0045218 |
zonula adherens maintenance(GO:0045218) |
| 1.3 |
8.1 |
GO:0051673 |
membrane disruption in other organism(GO:0051673) |
| 1.3 |
4.0 |
GO:0098502 |
DNA dephosphorylation(GO:0098502) |
| 1.3 |
12.0 |
GO:0021840 |
directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) |
| 1.3 |
4.0 |
GO:0060988 |
lipid tube assembly(GO:0060988) |
| 1.3 |
21.3 |
GO:0000733 |
DNA strand renaturation(GO:0000733) |
| 1.3 |
1.3 |
GO:0060967 |
negative regulation of posttranscriptional gene silencing(GO:0060149) negative regulation of gene silencing by miRNA(GO:0060965) negative regulation of gene silencing by RNA(GO:0060967) negative regulation of gene silencing(GO:0060969) |
| 1.3 |
5.3 |
GO:0042323 |
negative regulation of circadian sleep/wake cycle, non-REM sleep(GO:0042323) negative regulation of mucus secretion(GO:0070256) |
| 1.3 |
9.3 |
GO:0055129 |
L-proline biosynthetic process(GO:0055129) |
| 1.3 |
13.2 |
GO:0060666 |
dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 1.3 |
4.0 |
GO:0043095 |
regulation of GTP cyclohydrolase I activity(GO:0043095) negative regulation of GTP cyclohydrolase I activity(GO:0043105) |
| 1.3 |
1.3 |
GO:0051045 |
negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
| 1.3 |
10.4 |
GO:1901029 |
negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 1.3 |
5.2 |
GO:0044537 |
regulation of circulating fibrinogen levels(GO:0044537) |
| 1.3 |
2.6 |
GO:0090119 |
vesicle-mediated cholesterol transport(GO:0090119) |
| 1.3 |
10.3 |
GO:0050653 |
chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
| 1.3 |
6.4 |
GO:1903026 |
negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
| 1.3 |
6.4 |
GO:0003285 |
septum secundum development(GO:0003285) |
| 1.3 |
5.1 |
GO:0001189 |
RNA polymerase I transcriptional preinitiation complex assembly(GO:0001188) RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript(GO:0001189) |
| 1.3 |
1.3 |
GO:0003274 |
endocardial cushion fusion(GO:0003274) |
| 1.3 |
6.3 |
GO:1990086 |
lens fiber cell apoptotic process(GO:1990086) |
| 1.3 |
5.0 |
GO:0035752 |
lysosomal lumen pH elevation(GO:0035752) |
| 1.3 |
3.8 |
GO:0019860 |
uracil metabolic process(GO:0019860) |
| 1.2 |
3.7 |
GO:0007042 |
lysosomal lumen acidification(GO:0007042) |
| 1.2 |
5.0 |
GO:0090299 |
regulation of neural crest formation(GO:0090299) negative regulation of neural crest formation(GO:0090301) negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
| 1.2 |
1.2 |
GO:0032918 |
polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
| 1.2 |
22.2 |
GO:1901642 |
nucleoside transmembrane transport(GO:1901642) |
| 1.2 |
1.2 |
GO:0051969 |
regulation of transmission of nerve impulse(GO:0051969) |
| 1.2 |
18.3 |
GO:0006048 |
UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
| 1.2 |
2.4 |
GO:0000732 |
strand displacement(GO:0000732) |
| 1.2 |
4.9 |
GO:1903939 |
regulation of TORC2 signaling(GO:1903939) |
| 1.2 |
3.6 |
GO:0021919 |
BMP signaling pathway involved in spinal cord dorsal/ventral patterning(GO:0021919) |
| 1.2 |
4.8 |
GO:0006391 |
transcription initiation from mitochondrial promoter(GO:0006391) |
| 1.2 |
6.0 |
GO:0035105 |
sterol regulatory element binding protein import into nucleus(GO:0035105) |
| 1.2 |
10.7 |
GO:0046185 |
aldehyde catabolic process(GO:0046185) |
| 1.2 |
3.6 |
GO:0019287 |
isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
| 1.2 |
5.9 |
GO:0031296 |
B cell costimulation(GO:0031296) |
| 1.2 |
1.2 |
GO:0035461 |
vitamin transmembrane transport(GO:0035461) |
| 1.2 |
4.7 |
GO:0070844 |
misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
| 1.2 |
4.7 |
GO:0002268 |
follicular dendritic cell differentiation(GO:0002268) |
| 1.2 |
2.3 |
GO:0072204 |
cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
| 1.2 |
17.3 |
GO:0071318 |
cellular response to ATP(GO:0071318) |
| 1.2 |
15.0 |
GO:0018401 |
peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
| 1.2 |
3.5 |
GO:0038162 |
erythropoietin-mediated signaling pathway(GO:0038162) |
| 1.1 |
4.6 |
GO:0015911 |
plasma membrane long-chain fatty acid transport(GO:0015911) |
| 1.1 |
1.1 |
GO:0007352 |
zygotic specification of dorsal/ventral axis(GO:0007352) |
| 1.1 |
4.6 |
GO:0031508 |
pericentric heterochromatin assembly(GO:0031508) |
| 1.1 |
18.3 |
GO:1902101 |
positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of mitotic sister chromatid separation(GO:1901970) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
| 1.1 |
3.4 |
GO:2000824 |
negative regulation of androgen receptor activity(GO:2000824) |
| 1.1 |
4.6 |
GO:0032811 |
regulation of epinephrine secretion(GO:0014060) negative regulation of epinephrine secretion(GO:0032811) epinephrine secretion(GO:0048242) |
| 1.1 |
6.8 |
GO:0001561 |
fatty acid alpha-oxidation(GO:0001561) |
| 1.1 |
2.2 |
GO:0007412 |
axon target recognition(GO:0007412) |
| 1.1 |
14.6 |
GO:0043435 |
response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
| 1.1 |
13.4 |
GO:0071321 |
cellular response to cGMP(GO:0071321) |
| 1.1 |
3.4 |
GO:2000397 |
regulation of ubiquitin-dependent endocytosis(GO:2000395) positive regulation of ubiquitin-dependent endocytosis(GO:2000397) |
| 1.1 |
3.3 |
GO:1900369 |
negative regulation of RNA interference(GO:1900369) |
| 1.1 |
14.4 |
GO:0019227 |
neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 1.1 |
1.1 |
GO:0060584 |
regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
| 1.1 |
3.3 |
GO:0051086 |
chaperone mediated protein folding independent of cofactor(GO:0051086) |
| 1.1 |
5.5 |
GO:0000432 |
regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
| 1.1 |
3.3 |
GO:0032792 |
negative regulation of CREB transcription factor activity(GO:0032792) |
| 1.1 |
5.5 |
GO:0036343 |
psychomotor behavior(GO:0036343) |
| 1.1 |
2.2 |
GO:0043117 |
positive regulation of vascular permeability(GO:0043117) |
| 1.1 |
5.5 |
GO:0018364 |
peptidyl-glutamine methylation(GO:0018364) |
| 1.1 |
2.2 |
GO:0043096 |
purine nucleobase salvage(GO:0043096) |
| 1.1 |
8.7 |
GO:0071926 |
endocannabinoid signaling pathway(GO:0071926) |
| 1.1 |
6.5 |
GO:2000035 |
regulation of stem cell division(GO:2000035) |
| 1.1 |
8.6 |
GO:0006083 |
acetate metabolic process(GO:0006083) |
| 1.1 |
4.3 |
GO:0061304 |
retinal blood vessel morphogenesis(GO:0061304) |
| 1.1 |
3.2 |
GO:0045062 |
extrathymic T cell selection(GO:0045062) |
| 1.1 |
3.2 |
GO:0006434 |
seryl-tRNA aminoacylation(GO:0006434) |
| 1.1 |
3.2 |
GO:0097187 |
dentinogenesis(GO:0097187) |
| 1.1 |
7.4 |
GO:0019344 |
cysteine biosynthetic process(GO:0019344) |
| 1.1 |
1.1 |
GO:2000276 |
negative regulation of oxidative phosphorylation uncoupler activity(GO:2000276) |
| 1.1 |
3.2 |
GO:0045720 |
negative regulation of integrin biosynthetic process(GO:0045720) |
| 1.1 |
3.2 |
GO:0033091 |
positive regulation of immature T cell proliferation(GO:0033091) |
| 1.0 |
4.2 |
GO:0034499 |
late endosome to Golgi transport(GO:0034499) |
| 1.0 |
8.4 |
GO:0097461 |
ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
| 1.0 |
3.1 |
GO:0034164 |
negative regulation of toll-like receptor 9 signaling pathway(GO:0034164) |
| 1.0 |
3.1 |
GO:0043602 |
nitrate catabolic process(GO:0043602) nitric oxide catabolic process(GO:0046210) |
| 1.0 |
7.3 |
GO:0034154 |
toll-like receptor 7 signaling pathway(GO:0034154) |
| 1.0 |
1.0 |
GO:0048703 |
embryonic viscerocranium morphogenesis(GO:0048703) |
| 1.0 |
6.2 |
GO:0042986 |
positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
| 1.0 |
5.2 |
GO:1901536 |
negative regulation of DNA demethylation(GO:1901536) |
| 1.0 |
3.1 |
GO:0019516 |
lactate oxidation(GO:0019516) |
| 1.0 |
8.2 |
GO:0097350 |
neutrophil clearance(GO:0097350) |
| 1.0 |
2.0 |
GO:1900157 |
regulation of bone mineralization involved in bone maturation(GO:1900157) |
| 1.0 |
5.1 |
GO:0006528 |
asparagine metabolic process(GO:0006528) |
| 1.0 |
3.0 |
GO:0045819 |
positive regulation of glycogen catabolic process(GO:0045819) |
| 1.0 |
1.0 |
GO:1902512 |
positive regulation of apoptotic DNA fragmentation(GO:1902512) |
| 1.0 |
13.0 |
GO:0061087 |
positive regulation of histone H3-K27 methylation(GO:0061087) |
| 1.0 |
5.0 |
GO:0048807 |
female genitalia morphogenesis(GO:0048807) |
| 1.0 |
3.0 |
GO:0070634 |
transepithelial ammonium transport(GO:0070634) |
| 1.0 |
3.0 |
GO:0072179 |
nephric duct formation(GO:0072179) |
| 1.0 |
5.9 |
GO:0097460 |
ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
| 1.0 |
3.9 |
GO:0006601 |
creatine biosynthetic process(GO:0006601) |
| 1.0 |
3.0 |
GO:1902568 |
regulation of eosinophil degranulation(GO:0043309) positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
| 1.0 |
4.9 |
GO:0006287 |
base-excision repair, gap-filling(GO:0006287) |
| 1.0 |
2.9 |
GO:0060722 |
spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
| 1.0 |
12.7 |
GO:0006268 |
DNA unwinding involved in DNA replication(GO:0006268) |
| 1.0 |
2.9 |
GO:0006173 |
dADP biosynthetic process(GO:0006173) |
| 1.0 |
16.6 |
GO:0051006 |
positive regulation of lipoprotein lipase activity(GO:0051006) |
| 1.0 |
1.0 |
GO:1900037 |
regulation of cellular response to hypoxia(GO:1900037) |
| 1.0 |
6.8 |
GO:0071486 |
cellular response to high light intensity(GO:0071486) retinal rod cell apoptotic process(GO:0097473) |
| 1.0 |
1.9 |
GO:0031938 |
regulation of chromatin silencing at telomere(GO:0031938) |
| 1.0 |
4.8 |
GO:2000189 |
positive regulation of cholesterol homeostasis(GO:2000189) |
| 1.0 |
1.9 |
GO:0033625 |
positive regulation of integrin activation(GO:0033625) |
| 0.9 |
3.8 |
GO:2000188 |
regulation of cholesterol homeostasis(GO:2000188) |
| 0.9 |
0.9 |
GO:0006624 |
vacuolar protein processing(GO:0006624) |
| 0.9 |
3.8 |
GO:0033499 |
galactose catabolic process via UDP-galactose(GO:0033499) |
| 0.9 |
3.8 |
GO:0042126 |
nitrate metabolic process(GO:0042126) |
| 0.9 |
2.8 |
GO:0019401 |
glycerol biosynthetic process(GO:0006114) alditol biosynthetic process(GO:0019401) |
| 0.9 |
0.9 |
GO:0021769 |
orbitofrontal cortex development(GO:0021769) |
| 0.9 |
2.8 |
GO:1905000 |
regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
| 0.9 |
1.9 |
GO:0036016 |
response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
| 0.9 |
1.9 |
GO:0010767 |
regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage(GO:0010767) |
| 0.9 |
21.3 |
GO:0009223 |
pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
| 0.9 |
7.4 |
GO:0042997 |
negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
| 0.9 |
2.8 |
GO:1902303 |
negative regulation of potassium ion export(GO:1902303) |
| 0.9 |
5.5 |
GO:0060267 |
positive regulation of respiratory burst(GO:0060267) |
| 0.9 |
15.6 |
GO:0015886 |
heme transport(GO:0015886) |
| 0.9 |
9.2 |
GO:0097070 |
ductus arteriosus closure(GO:0097070) |
| 0.9 |
11.0 |
GO:0010032 |
meiotic chromosome condensation(GO:0010032) |
| 0.9 |
5.5 |
GO:0030538 |
embryonic genitalia morphogenesis(GO:0030538) |
| 0.9 |
2.7 |
GO:2000705 |
dense core granule biogenesis(GO:0061110) regulation of dense core granule biogenesis(GO:2000705) |
| 0.9 |
2.7 |
GO:0070512 |
regulation of histone H4-K20 methylation(GO:0070510) positive regulation of histone H4-K20 methylation(GO:0070512) |
| 0.9 |
5.4 |
GO:0050957 |
equilibrioception(GO:0050957) |
| 0.9 |
7.2 |
GO:0090116 |
C-5 methylation of cytosine(GO:0090116) |
| 0.9 |
0.9 |
GO:0061032 |
visceral serous pericardium development(GO:0061032) |
| 0.9 |
17.1 |
GO:0051103 |
DNA ligation involved in DNA repair(GO:0051103) |
| 0.9 |
2.7 |
GO:2000525 |
regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
| 0.9 |
7.2 |
GO:0006335 |
DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.9 |
2.7 |
GO:0002023 |
reduction of food intake in response to dietary excess(GO:0002023) |
| 0.9 |
6.3 |
GO:0019075 |
virus maturation(GO:0019075) |
| 0.9 |
0.9 |
GO:0009146 |
purine nucleoside triphosphate catabolic process(GO:0009146) |
| 0.9 |
0.9 |
GO:0007089 |
traversing start control point of mitotic cell cycle(GO:0007089) |
| 0.9 |
4.5 |
GO:2000672 |
negative regulation of motor neuron apoptotic process(GO:2000672) |
| 0.9 |
2.7 |
GO:0018194 |
N-terminal peptidyl-alanine methylation(GO:0018011) N-terminal peptidyl-alanine trimethylation(GO:0018012) N-terminal peptidyl-glycine methylation(GO:0018013) N-terminal peptidyl-proline dimethylation(GO:0018016) peptidyl-alanine modification(GO:0018194) N-terminal peptidyl-proline methylation(GO:0035568) N-terminal peptidyl-serine methylation(GO:0035570) N-terminal peptidyl-serine dimethylation(GO:0035572) N-terminal peptidyl-serine trimethylation(GO:0035573) |
| 0.9 |
0.9 |
GO:0031339 |
negative regulation of vesicle fusion(GO:0031339) |
| 0.9 |
4.5 |
GO:1901091 |
regulation of protein tetramerization(GO:1901090) negative regulation of protein tetramerization(GO:1901091) regulation of protein homotetramerization(GO:1901093) negative regulation of protein homotetramerization(GO:1901094) |
| 0.9 |
17.9 |
GO:1990001 |
inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
| 0.9 |
0.9 |
GO:0046015 |
regulation of transcription by glucose(GO:0046015) |
| 0.9 |
2.7 |
GO:1903347 |
negative regulation of bicellular tight junction assembly(GO:1903347) |
| 0.9 |
11.5 |
GO:0030091 |
protein repair(GO:0030091) |
| 0.9 |
1.8 |
GO:0021707 |
cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
| 0.9 |
2.6 |
GO:0048210 |
Golgi vesicle fusion to target membrane(GO:0048210) |
| 0.9 |
35.1 |
GO:0007214 |
gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.9 |
9.6 |
GO:0097500 |
receptor localization to nonmotile primary cilium(GO:0097500) |
| 0.9 |
3.5 |
GO:0035668 |
TRAM-dependent toll-like receptor signaling pathway(GO:0035668) TRAM-dependent toll-like receptor 4 signaling pathway(GO:0035669) |
| 0.9 |
3.5 |
GO:0072709 |
cellular response to sorbitol(GO:0072709) |
| 0.9 |
4.4 |
GO:0071409 |
cellular response to cycloheximide(GO:0071409) |
| 0.9 |
4.3 |
GO:0060371 |
regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
| 0.9 |
1.7 |
GO:0060796 |
regulation of transcription involved in primary germ layer cell fate commitment(GO:0060796) |
| 0.9 |
4.3 |
GO:0071051 |
polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
| 0.9 |
0.9 |
GO:1903401 |
L-lysine transmembrane transport(GO:1903401) |
| 0.9 |
3.4 |
GO:0035948 |
positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
| 0.9 |
1.7 |
GO:0045590 |
negative regulation of regulatory T cell differentiation(GO:0045590) |
| 0.9 |
2.6 |
GO:0032354 |
response to follicle-stimulating hormone(GO:0032354) |
| 0.8 |
6.8 |
GO:0006701 |
progesterone biosynthetic process(GO:0006701) |
| 0.8 |
0.8 |
GO:0021516 |
dorsal spinal cord development(GO:0021516) |
| 0.8 |
11.0 |
GO:0051152 |
positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.8 |
0.8 |
GO:0019852 |
L-ascorbic acid metabolic process(GO:0019852) |
| 0.8 |
5.9 |
GO:0097428 |
protein maturation by iron-sulfur cluster transfer(GO:0097428) |
| 0.8 |
3.4 |
GO:0010701 |
positive regulation of norepinephrine secretion(GO:0010701) |
| 0.8 |
2.5 |
GO:0003150 |
muscular septum morphogenesis(GO:0003150) |
| 0.8 |
5.0 |
GO:0045903 |
positive regulation of translational fidelity(GO:0045903) |
| 0.8 |
1.7 |
GO:1904938 |
dopaminergic neuron axon guidance(GO:0036514) serotonergic neuron axon guidance(GO:0036515) planar cell polarity pathway involved in axon guidance(GO:1904938) |
| 0.8 |
1.6 |
GO:0060024 |
rhythmic synaptic transmission(GO:0060024) |
| 0.8 |
0.8 |
GO:0035404 |
histone-serine phosphorylation(GO:0035404) |
| 0.8 |
4.1 |
GO:0015822 |
mitochondrial ornithine transport(GO:0000066) ornithine transport(GO:0015822) |
| 0.8 |
3.3 |
GO:1903721 |
regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
| 0.8 |
1.6 |
GO:0015783 |
GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
| 0.8 |
7.3 |
GO:0021527 |
spinal cord association neuron differentiation(GO:0021527) |
| 0.8 |
0.8 |
GO:0046100 |
hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
| 0.8 |
0.8 |
GO:0090187 |
positive regulation of pancreatic juice secretion(GO:0090187) |
| 0.8 |
12.1 |
GO:0006228 |
UTP biosynthetic process(GO:0006228) |
| 0.8 |
3.2 |
GO:0042264 |
peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 0.8 |
2.4 |
GO:0045356 |
positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
| 0.8 |
0.8 |
GO:0032425 |
regulation of mismatch repair(GO:0032423) positive regulation of mismatch repair(GO:0032425) |
| 0.8 |
1.6 |
GO:0000479 |
endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) |
| 0.8 |
4.0 |
GO:0007135 |
meiosis II(GO:0007135) |
| 0.8 |
2.4 |
GO:0010159 |
specification of organ position(GO:0010159) |
| 0.8 |
7.2 |
GO:0061002 |
negative regulation of dendritic spine morphogenesis(GO:0061002) |
| 0.8 |
0.8 |
GO:0060664 |
epithelial cell proliferation involved in salivary gland morphogenesis(GO:0060664) |
| 0.8 |
2.4 |
GO:0006271 |
DNA strand elongation involved in DNA replication(GO:0006271) |
| 0.8 |
8.7 |
GO:0071787 |
endoplasmic reticulum tubular network assembly(GO:0071787) |
| 0.8 |
4.8 |
GO:2000172 |
regulation of branching morphogenesis of a nerve(GO:2000172) |
| 0.8 |
4.8 |
GO:0016321 |
female meiosis chromosome segregation(GO:0016321) |
| 0.8 |
4.7 |
GO:0032487 |
regulation of Rap protein signal transduction(GO:0032487) |
| 0.8 |
3.9 |
GO:0006668 |
sphinganine-1-phosphate metabolic process(GO:0006668) |
| 0.8 |
3.1 |
GO:0051754 |
meiotic sister chromatid cohesion, centromeric(GO:0051754) |
| 0.8 |
8.6 |
GO:0043951 |
negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.8 |
2.3 |
GO:0070676 |
intralumenal vesicle formation(GO:0070676) |
| 0.8 |
6.3 |
GO:0032483 |
regulation of Rab protein signal transduction(GO:0032483) |
| 0.8 |
3.1 |
GO:0009052 |
pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
| 0.8 |
4.6 |
GO:0045627 |
positive regulation of T-helper 1 cell differentiation(GO:0045627) |
| 0.8 |
3.8 |
GO:0006269 |
DNA replication, synthesis of RNA primer(GO:0006269) |
| 0.8 |
33.0 |
GO:0031055 |
chromatin remodeling at centromere(GO:0031055) |
| 0.8 |
0.8 |
GO:0051660 |
establishment of centrosome localization(GO:0051660) |
| 0.8 |
8.4 |
GO:0070874 |
negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
| 0.8 |
1.5 |
GO:0060809 |
mesodermal to mesenchymal transition involved in gastrulation(GO:0060809) |
| 0.8 |
3.0 |
GO:0098968 |
neurotransmitter receptor transport postsynaptic membrane to endosome(GO:0098968) |
| 0.8 |
2.3 |
GO:1902255 |
positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
| 0.8 |
3.8 |
GO:0010989 |
negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
| 0.8 |
2.3 |
GO:1903377 |
negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.8 |
6.0 |
GO:0002315 |
marginal zone B cell differentiation(GO:0002315) |
| 0.8 |
0.8 |
GO:0042732 |
D-xylose metabolic process(GO:0042732) |
| 0.8 |
4.5 |
GO:0010693 |
negative regulation of alkaline phosphatase activity(GO:0010693) |
| 0.8 |
3.8 |
GO:0000469 |
cleavage involved in rRNA processing(GO:0000469) |
| 0.7 |
3.7 |
GO:0030222 |
eosinophil differentiation(GO:0030222) |
| 0.7 |
1.5 |
GO:0060197 |
cloacal septation(GO:0060197) |
| 0.7 |
10.4 |
GO:0043985 |
histone H4-R3 methylation(GO:0043985) |
| 0.7 |
3.7 |
GO:0060830 |
ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
| 0.7 |
3.0 |
GO:0016267 |
O-glycan processing, core 1(GO:0016267) |
| 0.7 |
0.7 |
GO:1903903 |
regulation of establishment of T cell polarity(GO:1903903) |
| 0.7 |
2.2 |
GO:0006663 |
platelet activating factor biosynthetic process(GO:0006663) |
| 0.7 |
6.6 |
GO:0060313 |
negative regulation of blood vessel remodeling(GO:0060313) |
| 0.7 |
0.7 |
GO:0006167 |
AMP biosynthetic process(GO:0006167) |
| 0.7 |
1.5 |
GO:2000381 |
negative regulation of mesoderm development(GO:2000381) |
| 0.7 |
0.7 |
GO:0035864 |
response to potassium ion(GO:0035864) |
| 0.7 |
3.6 |
GO:1902268 |
negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.7 |
5.8 |
GO:0070307 |
lens fiber cell development(GO:0070307) |
| 0.7 |
1.5 |
GO:0060454 |
positive regulation of gastric acid secretion(GO:0060454) |
| 0.7 |
5.1 |
GO:0019530 |
taurine metabolic process(GO:0019530) |
| 0.7 |
3.6 |
GO:0046677 |
response to antibiotic(GO:0046677) |
| 0.7 |
2.2 |
GO:0072156 |
distal tubule morphogenesis(GO:0072156) |
| 0.7 |
5.7 |
GO:0000707 |
meiotic DNA recombinase assembly(GO:0000707) |
| 0.7 |
2.9 |
GO:0018171 |
peptidyl-cysteine oxidation(GO:0018171) |
| 0.7 |
13.6 |
GO:0031163 |
iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.7 |
0.7 |
GO:0042373 |
vitamin K metabolic process(GO:0042373) |
| 0.7 |
2.9 |
GO:0019747 |
regulation of isoprenoid metabolic process(GO:0019747) |
| 0.7 |
15.6 |
GO:0022038 |
corpus callosum development(GO:0022038) |
| 0.7 |
0.7 |
GO:0045620 |
negative regulation of lymphocyte differentiation(GO:0045620) |
| 0.7 |
2.8 |
GO:0015910 |
peroxisomal long-chain fatty acid import(GO:0015910) |
| 0.7 |
7.0 |
GO:0075044 |
autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
| 0.7 |
3.5 |
GO:0007181 |
transforming growth factor beta receptor complex assembly(GO:0007181) |
| 0.7 |
0.7 |
GO:0060823 |
canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060823) |
| 0.7 |
15.3 |
GO:0006703 |
estrogen biosynthetic process(GO:0006703) |
| 0.7 |
3.5 |
GO:0051292 |
nuclear pore organization(GO:0006999) nuclear pore complex assembly(GO:0051292) |
| 0.7 |
5.6 |
GO:0030174 |
regulation of DNA-dependent DNA replication initiation(GO:0030174) |
| 0.7 |
20.1 |
GO:0032060 |
bleb assembly(GO:0032060) |
| 0.7 |
2.8 |
GO:0046462 |
monoacylglycerol metabolic process(GO:0046462) monoacylglycerol catabolic process(GO:0052651) |
| 0.7 |
2.1 |
GO:0043504 |
mitochondrial DNA repair(GO:0043504) |
| 0.7 |
6.2 |
GO:0042756 |
drinking behavior(GO:0042756) |
| 0.7 |
2.8 |
GO:2000298 |
regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
| 0.7 |
2.1 |
GO:0021898 |
regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) cerebral cortex GABAergic interneuron fate commitment(GO:0021893) commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) positive regulation of neural retina development(GO:0061075) positive regulation of retina development in camera-type eye(GO:1902868) positive regulation of amacrine cell differentiation(GO:1902871) |
| 0.7 |
2.1 |
GO:0071963 |
establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 0.7 |
18.4 |
GO:0006744 |
ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
| 0.7 |
2.7 |
GO:0008355 |
olfactory learning(GO:0008355) |
| 0.7 |
15.7 |
GO:0030150 |
protein import into mitochondrial matrix(GO:0030150) |
| 0.7 |
2.0 |
GO:0060385 |
axonogenesis involved in innervation(GO:0060385) |
| 0.7 |
2.0 |
GO:0044034 |
negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
| 0.7 |
9.5 |
GO:0035269 |
protein O-linked mannosylation(GO:0035269) |
| 0.7 |
3.4 |
GO:0061364 |
apoptotic process involved in luteolysis(GO:0061364) |
| 0.7 |
0.7 |
GO:0006481 |
C-terminal protein methylation(GO:0006481) |
| 0.7 |
4.1 |
GO:1903232 |
melanosome assembly(GO:1903232) |
| 0.7 |
9.5 |
GO:0035331 |
negative regulation of hippo signaling(GO:0035331) |
| 0.7 |
3.4 |
GO:0070213 |
protein auto-ADP-ribosylation(GO:0070213) |
| 0.7 |
4.7 |
GO:0000920 |
cell separation after cytokinesis(GO:0000920) |
| 0.7 |
5.4 |
GO:0032310 |
prostaglandin secretion(GO:0032310) |
| 0.7 |
4.7 |
GO:2000809 |
positive regulation of synaptic vesicle clustering(GO:2000809) |
| 0.7 |
0.7 |
GO:1901798 |
positive regulation of signal transduction by p53 class mediator(GO:1901798) |
| 0.7 |
0.7 |
GO:0010726 |
positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
| 0.7 |
2.0 |
GO:1901873 |
regulation of post-translational protein modification(GO:1901873) |
| 0.7 |
1.3 |
GO:0061074 |
regulation of neural retina development(GO:0061074) |
| 0.7 |
1.3 |
GO:0048369 |
lateral mesoderm morphogenesis(GO:0048369) lateral mesoderm formation(GO:0048370) |
| 0.7 |
4.7 |
GO:0035087 |
siRNA loading onto RISC involved in RNA interference(GO:0035087) |
| 0.7 |
0.7 |
GO:0038108 |
negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
| 0.7 |
4.0 |
GO:0009211 |
pyrimidine deoxyribonucleoside triphosphate metabolic process(GO:0009211) dTTP metabolic process(GO:0046075) |
| 0.7 |
2.0 |
GO:0043000 |
Golgi to plasma membrane CFTR protein transport(GO:0043000) |
| 0.7 |
0.7 |
GO:0034759 |
regulation of iron ion transport(GO:0034756) regulation of iron ion transmembrane transport(GO:0034759) |
| 0.7 |
2.0 |
GO:0070407 |
oxidation-dependent protein catabolic process(GO:0070407) |
| 0.7 |
2.0 |
GO:1900133 |
regulation of renin secretion into blood stream(GO:1900133) |
| 0.7 |
0.7 |
GO:0035989 |
tendon development(GO:0035989) |
| 0.7 |
3.9 |
GO:0016480 |
negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.7 |
5.9 |
GO:0022417 |
protein maturation by protein folding(GO:0022417) |
| 0.6 |
3.9 |
GO:0086021 |
SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) |
| 0.6 |
2.6 |
GO:1903803 |
glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
| 0.6 |
3.9 |
GO:0035897 |
proteolysis in other organism(GO:0035897) |
| 0.6 |
0.6 |
GO:0060831 |
smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901620) negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
| 0.6 |
10.9 |
GO:1904714 |
regulation of chaperone-mediated autophagy(GO:1904714) |
| 0.6 |
7.7 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 0.6 |
2.6 |
GO:2000611 |
positive regulation of thyroid hormone generation(GO:2000611) |
| 0.6 |
1.9 |
GO:0042421 |
norepinephrine biosynthetic process(GO:0042421) |
| 0.6 |
5.1 |
GO:0060136 |
embryonic process involved in female pregnancy(GO:0060136) |
| 0.6 |
3.8 |
GO:1902231 |
positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.6 |
2.5 |
GO:0003335 |
corneocyte development(GO:0003335) |
| 0.6 |
1.9 |
GO:2000196 |
positive regulation of female gonad development(GO:2000196) |
| 0.6 |
3.2 |
GO:0034395 |
regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
| 0.6 |
2.5 |
GO:0071348 |
cellular response to interleukin-11(GO:0071348) |
| 0.6 |
1.9 |
GO:2001033 |
negative regulation of double-strand break repair via nonhomologous end joining(GO:2001033) |
| 0.6 |
2.5 |
GO:0033173 |
calcineurin-NFAT signaling cascade(GO:0033173) |
| 0.6 |
0.6 |
GO:0043987 |
histone H3-S10 phosphorylation(GO:0043987) |
| 0.6 |
2.5 |
GO:0072344 |
rescue of stalled ribosome(GO:0072344) |
| 0.6 |
0.6 |
GO:0035405 |
histone-threonine phosphorylation(GO:0035405) |
| 0.6 |
1.9 |
GO:0060061 |
Spemann organizer formation(GO:0060061) |
| 0.6 |
11.8 |
GO:0006107 |
oxaloacetate metabolic process(GO:0006107) |
| 0.6 |
7.4 |
GO:0009304 |
tRNA transcription(GO:0009304) |
| 0.6 |
11.1 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 0.6 |
1.8 |
GO:0060730 |
regulation of intestinal epithelial structure maintenance(GO:0060730) |
| 0.6 |
5.5 |
GO:0035965 |
cardiolipin acyl-chain remodeling(GO:0035965) |
| 0.6 |
1.8 |
GO:0006097 |
glyoxylate cycle(GO:0006097) |
| 0.6 |
1.8 |
GO:1990697 |
protein depalmitoleylation(GO:1990697) |
| 0.6 |
1.2 |
GO:0009644 |
response to high light intensity(GO:0009644) |
| 0.6 |
0.6 |
GO:1904896 |
ESCRT complex disassembly(GO:1904896) ESCRT III complex disassembly(GO:1904903) |
| 0.6 |
0.6 |
GO:0072197 |
ureter morphogenesis(GO:0072197) |
| 0.6 |
8.4 |
GO:0021520 |
spinal cord motor neuron cell fate specification(GO:0021520) |
| 0.6 |
3.6 |
GO:2000676 |
positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
| 0.6 |
1.8 |
GO:0042137 |
sequestering of neurotransmitter(GO:0042137) |
| 0.6 |
1.8 |
GO:1901207 |
regulation of heart looping(GO:1901207) |
| 0.6 |
2.4 |
GO:1901165 |
positive regulation of trophoblast cell migration(GO:1901165) |
| 0.6 |
2.4 |
GO:0060426 |
lung vasculature development(GO:0060426) |
| 0.6 |
2.4 |
GO:0016598 |
protein arginylation(GO:0016598) |
| 0.6 |
7.1 |
GO:0043116 |
negative regulation of vascular permeability(GO:0043116) |
| 0.6 |
1.2 |
GO:1904385 |
cellular response to angiotensin(GO:1904385) |
| 0.6 |
3.5 |
GO:0034227 |
tRNA thio-modification(GO:0034227) |
| 0.6 |
20.6 |
GO:0006270 |
DNA replication initiation(GO:0006270) |
| 0.6 |
3.5 |
GO:1901523 |
leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
| 0.6 |
9.4 |
GO:0035810 |
positive regulation of urine volume(GO:0035810) |
| 0.6 |
11.1 |
GO:0019532 |
oxalate transport(GO:0019532) |
| 0.6 |
0.6 |
GO:0061484 |
hematopoietic stem cell homeostasis(GO:0061484) |
| 0.6 |
2.3 |
GO:0060392 |
negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 0.6 |
1.2 |
GO:0021523 |
somatic motor neuron differentiation(GO:0021523) |
| 0.6 |
1.2 |
GO:1900738 |
positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
| 0.6 |
4.7 |
GO:0097068 |
response to thyroxine(GO:0097068) response to L-phenylalanine derivative(GO:1904386) |
| 0.6 |
2.3 |
GO:0006931 |
substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.6 |
2.3 |
GO:0006390 |
transcription from mitochondrial promoter(GO:0006390) |
| 0.6 |
5.2 |
GO:0038003 |
opioid receptor signaling pathway(GO:0038003) |
| 0.6 |
2.9 |
GO:0006285 |
base-excision repair, AP site formation(GO:0006285) |
| 0.6 |
3.5 |
GO:0099601 |
regulation of neurotransmitter receptor activity(GO:0099601) |
| 0.6 |
0.6 |
GO:2001184 |
positive regulation of interleukin-12 secretion(GO:2001184) |
| 0.6 |
4.0 |
GO:0008063 |
Toll signaling pathway(GO:0008063) |
| 0.6 |
12.1 |
GO:0040015 |
negative regulation of multicellular organism growth(GO:0040015) |
| 0.6 |
1.7 |
GO:1901202 |
negative regulation of extracellular matrix assembly(GO:1901202) |
| 0.6 |
1.7 |
GO:0097091 |
synaptic vesicle clustering(GO:0097091) |
| 0.6 |
1.1 |
GO:0035787 |
cell migration involved in kidney development(GO:0035787) |
| 0.6 |
3.4 |
GO:0014012 |
peripheral nervous system axon regeneration(GO:0014012) |
| 0.6 |
15.4 |
GO:0016254 |
preassembly of GPI anchor in ER membrane(GO:0016254) |
| 0.6 |
3.4 |
GO:0015888 |
thiamine transport(GO:0015888) |
| 0.6 |
8.5 |
GO:0045717 |
negative regulation of fatty acid biosynthetic process(GO:0045717) |
| 0.6 |
1.1 |
GO:1904059 |
regulation of locomotor rhythm(GO:1904059) |
| 0.6 |
12.4 |
GO:0000028 |
ribosomal small subunit assembly(GO:0000028) |
| 0.6 |
2.8 |
GO:0061737 |
leukotriene signaling pathway(GO:0061737) |
| 0.6 |
0.6 |
GO:0060037 |
pharyngeal system development(GO:0060037) |
| 0.6 |
1.7 |
GO:0060762 |
regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
| 0.6 |
2.2 |
GO:1903566 |
positive regulation of protein localization to cilium(GO:1903566) |
| 0.6 |
1.7 |
GO:0019276 |
UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
| 0.6 |
3.9 |
GO:1904636 |
response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
| 0.6 |
4.5 |
GO:0006108 |
malate metabolic process(GO:0006108) |
| 0.6 |
1.7 |
GO:0048250 |
mitochondrial iron ion transport(GO:0048250) |
| 0.6 |
0.6 |
GO:0033058 |
directional locomotion(GO:0033058) |
| 0.6 |
13.8 |
GO:0006488 |
dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
| 0.6 |
5.0 |
GO:0070995 |
NADPH oxidation(GO:0070995) |
| 0.6 |
0.6 |
GO:0051418 |
interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 0.5 |
4.4 |
GO:0050893 |
sensory processing(GO:0050893) |
| 0.5 |
1.1 |
GO:0034443 |
negative regulation of lipoprotein oxidation(GO:0034443) |
| 0.5 |
0.5 |
GO:0009092 |
homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
| 0.5 |
2.2 |
GO:0000912 |
assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
| 0.5 |
2.2 |
GO:0015684 |
ferrous iron transport(GO:0015684) ferrous iron transmembrane transport(GO:1903874) |
| 0.5 |
2.2 |
GO:0000103 |
sulfate assimilation(GO:0000103) |
| 0.5 |
1.6 |
GO:0051685 |
maintenance of ER location(GO:0051685) |
| 0.5 |
2.2 |
GO:0072334 |
UDP-galactose transport(GO:0015785) UDP-galactose transmembrane transport(GO:0072334) |
| 0.5 |
1.6 |
GO:0060380 |
regulation of single-stranded telomeric DNA binding(GO:0060380) positive regulation of single-stranded telomeric DNA binding(GO:0060381) |
| 0.5 |
5.4 |
GO:0035021 |
negative regulation of Rac protein signal transduction(GO:0035021) |
| 0.5 |
0.5 |
GO:0033632 |
regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
| 0.5 |
2.7 |
GO:1905098 |
negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
| 0.5 |
2.1 |
GO:0031443 |
fast-twitch skeletal muscle fiber contraction(GO:0031443) |
| 0.5 |
9.0 |
GO:0010990 |
regulation of SMAD protein complex assembly(GO:0010990) |
| 0.5 |
2.1 |
GO:0090410 |
malonate catabolic process(GO:0090410) |
| 0.5 |
1.1 |
GO:0044804 |
nucleophagy(GO:0044804) |
| 0.5 |
4.2 |
GO:0003065 |
positive regulation of heart rate by epinephrine(GO:0003065) |
| 0.5 |
1.6 |
GO:0080120 |
CAAX-box protein processing(GO:0071586) CAAX-box protein maturation(GO:0080120) |
| 0.5 |
4.2 |
GO:0044211 |
CTP salvage(GO:0044211) |
| 0.5 |
4.8 |
GO:1901843 |
positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
| 0.5 |
0.5 |
GO:0030851 |
granulocyte differentiation(GO:0030851) |
| 0.5 |
8.4 |
GO:0031167 |
rRNA methylation(GO:0031167) |
| 0.5 |
1.1 |
GO:0070315 |
G1 to G0 transition involved in cell differentiation(GO:0070315) |
| 0.5 |
1.6 |
GO:0042816 |
vitamin B6 metabolic process(GO:0042816) |
| 0.5 |
1.6 |
GO:0034553 |
respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
| 0.5 |
1.0 |
GO:0035712 |
T-helper 2 cell activation(GO:0035712) regulation of T-helper 2 cell activation(GO:2000569) positive regulation of T-helper 2 cell activation(GO:2000570) |
| 0.5 |
3.1 |
GO:0048295 |
positive regulation of isotype switching to IgE isotypes(GO:0048295) |
| 0.5 |
3.1 |
GO:0072112 |
renal filtration cell differentiation(GO:0061318) glomerular visceral epithelial cell differentiation(GO:0072112) |
| 0.5 |
6.2 |
GO:0060390 |
regulation of SMAD protein import into nucleus(GO:0060390) |
| 0.5 |
2.1 |
GO:0072183 |
negative regulation by virus of viral protein levels in host cell(GO:0046725) negative regulation of nephron tubule epithelial cell differentiation(GO:0072183) negative regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072308) negative regulation of epithelial cell differentiation involved in kidney development(GO:2000697) |
| 0.5 |
15.9 |
GO:0008535 |
respiratory chain complex IV assembly(GO:0008535) |
| 0.5 |
5.7 |
GO:0045723 |
positive regulation of fatty acid biosynthetic process(GO:0045723) |
| 0.5 |
1.0 |
GO:2001176 |
mediator complex assembly(GO:0036034) regulation of mediator complex assembly(GO:2001176) positive regulation of mediator complex assembly(GO:2001178) |
| 0.5 |
4.1 |
GO:0050747 |
positive regulation of lipoprotein metabolic process(GO:0050747) |
| 0.5 |
0.5 |
GO:0036309 |
protein localization to M-band(GO:0036309) |
| 0.5 |
6.1 |
GO:1901223 |
negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 0.5 |
1.5 |
GO:1904617 |
negative regulation of actin filament binding(GO:1904530) negative regulation of actin binding(GO:1904617) |
| 0.5 |
2.6 |
GO:1903659 |
regulation of complement-dependent cytotoxicity(GO:1903659) |
| 0.5 |
2.0 |
GO:1904398 |
positive regulation of neuromuscular junction development(GO:1904398) |
| 0.5 |
3.1 |
GO:0015691 |
cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
| 0.5 |
1.5 |
GO:0060023 |
soft palate development(GO:0060023) |
| 0.5 |
6.1 |
GO:0006011 |
UDP-glucose metabolic process(GO:0006011) |
| 0.5 |
2.0 |
GO:0000412 |
histone peptidyl-prolyl isomerization(GO:0000412) |
| 0.5 |
1.0 |
GO:0097029 |
mature conventional dendritic cell differentiation(GO:0097029) |
| 0.5 |
3.0 |
GO:0045900 |
negative regulation of translational elongation(GO:0045900) |
| 0.5 |
2.5 |
GO:0046349 |
amino sugar biosynthetic process(GO:0046349) |
| 0.5 |
0.5 |
GO:0001768 |
establishment of T cell polarity(GO:0001768) |
| 0.5 |
1.0 |
GO:0006203 |
dGTP catabolic process(GO:0006203) |
| 0.5 |
2.5 |
GO:0034421 |
post-translational protein acetylation(GO:0034421) |
| 0.5 |
1.5 |
GO:0045075 |
interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
| 0.5 |
3.0 |
GO:0000160 |
phosphorelay signal transduction system(GO:0000160) |
| 0.5 |
1.0 |
GO:0072321 |
chaperone-mediated protein transport(GO:0072321) |
| 0.5 |
4.5 |
GO:0045602 |
negative regulation of endothelial cell differentiation(GO:0045602) |
| 0.5 |
1.0 |
GO:0072249 |
metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
| 0.5 |
0.5 |
GO:0003032 |
detection of oxygen(GO:0003032) |
| 0.5 |
7.0 |
GO:0033015 |
porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.5 |
3.5 |
GO:0030951 |
establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 0.5 |
1.5 |
GO:0021979 |
hypothalamus cell differentiation(GO:0021979) |
| 0.5 |
3.5 |
GO:0097278 |
complement-dependent cytotoxicity(GO:0097278) |
| 0.5 |
3.5 |
GO:1903288 |
positive regulation of potassium ion import(GO:1903288) |
| 0.5 |
6.4 |
GO:0050961 |
detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
| 0.5 |
3.9 |
GO:0071395 |
response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
| 0.5 |
1.0 |
GO:0021798 |
forebrain dorsal/ventral pattern formation(GO:0021798) |
| 0.5 |
0.5 |
GO:0034699 |
response to luteinizing hormone(GO:0034699) |
| 0.5 |
1.0 |
GO:1904529 |
regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) activation of protein kinase C activity(GO:1990051) |
| 0.5 |
0.5 |
GO:1903630 |
regulation of aminoacyl-tRNA ligase activity(GO:1903630) |
| 0.5 |
1.0 |
GO:0085020 |
protein K6-linked ubiquitination(GO:0085020) |
| 0.5 |
3.9 |
GO:0034244 |
negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.5 |
2.0 |
GO:0002118 |
aggressive behavior(GO:0002118) |
| 0.5 |
3.4 |
GO:0030167 |
proteoglycan catabolic process(GO:0030167) |
| 0.5 |
5.3 |
GO:1904779 |
regulation of protein localization to centrosome(GO:1904779) |
| 0.5 |
9.7 |
GO:0050861 |
positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 0.5 |
0.5 |
GO:0006990 |
positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
| 0.5 |
36.7 |
GO:0007077 |
mitotic nuclear envelope disassembly(GO:0007077) |
| 0.5 |
2.4 |
GO:0035330 |
regulation of hippo signaling(GO:0035330) |
| 0.5 |
1.4 |
GO:0010520 |
regulation of reciprocal meiotic recombination(GO:0010520) |
| 0.5 |
5.7 |
GO:1990440 |
positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
| 0.5 |
1.4 |
GO:0044313 |
protein K6-linked deubiquitination(GO:0044313) |
| 0.5 |
6.2 |
GO:0048251 |
elastic fiber assembly(GO:0048251) |
| 0.5 |
1.9 |
GO:0060179 |
male mating behavior(GO:0060179) |
| 0.5 |
9.5 |
GO:0051601 |
exocyst localization(GO:0051601) |
| 0.5 |
16.6 |
GO:0007094 |
mitotic spindle assembly checkpoint(GO:0007094) spindle assembly checkpoint(GO:0071173) |
| 0.5 |
11.4 |
GO:2000311 |
regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.5 |
0.5 |
GO:1902616 |
acyl carnitine transport(GO:0006844) acyl carnitine transmembrane transport(GO:1902616) |
| 0.5 |
12.2 |
GO:0045005 |
DNA-dependent DNA replication maintenance of fidelity(GO:0045005) |
| 0.5 |
2.4 |
GO:0071874 |
response to norepinephrine(GO:0071873) cellular response to norepinephrine stimulus(GO:0071874) |
| 0.5 |
0.9 |
GO:0035720 |
intraciliary anterograde transport(GO:0035720) |
| 0.5 |
5.6 |
GO:0006527 |
arginine catabolic process(GO:0006527) |
| 0.5 |
2.3 |
GO:0050915 |
sensory perception of sour taste(GO:0050915) |
| 0.5 |
2.3 |
GO:0034224 |
cellular response to zinc ion starvation(GO:0034224) |
| 0.5 |
0.9 |
GO:0044205 |
'de novo' UMP biosynthetic process(GO:0044205) |
| 0.5 |
1.4 |
GO:0032581 |
ER-dependent peroxisome organization(GO:0032581) |
| 0.5 |
1.4 |
GO:0072428 |
signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
| 0.5 |
0.5 |
GO:0032687 |
negative regulation of interferon-alpha production(GO:0032687) |
| 0.5 |
1.9 |
GO:0097327 |
response to antineoplastic agent(GO:0097327) |
| 0.5 |
6.1 |
GO:0006122 |
mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.5 |
4.2 |
GO:0071316 |
cellular response to nicotine(GO:0071316) |
| 0.5 |
10.2 |
GO:0015893 |
drug transport(GO:0015893) |
| 0.5 |
2.8 |
GO:0010911 |
regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000371) positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000373) |
| 0.5 |
0.9 |
GO:0043496 |
regulation of protein homodimerization activity(GO:0043496) |
| 0.5 |
6.4 |
GO:0030321 |
transepithelial chloride transport(GO:0030321) |
| 0.5 |
3.7 |
GO:0035610 |
protein side chain deglutamylation(GO:0035610) |
| 0.5 |
1.8 |
GO:0060335 |
positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
| 0.5 |
0.5 |
GO:1904869 |
protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
| 0.5 |
10.4 |
GO:0006123 |
mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.5 |
3.2 |
GO:0010918 |
positive regulation of mitochondrial membrane potential(GO:0010918) |
| 0.4 |
1.3 |
GO:1902824 |
positive regulation of late endosome to lysosome transport(GO:1902824) |
| 0.4 |
1.3 |
GO:0006524 |
alanine metabolic process(GO:0006522) alanine catabolic process(GO:0006524) pyruvate family amino acid metabolic process(GO:0009078) pyruvate family amino acid catabolic process(GO:0009080) |
| 0.4 |
3.1 |
GO:1904431 |
positive regulation of t-circle formation(GO:1904431) |
| 0.4 |
4.5 |
GO:0046485 |
ether lipid metabolic process(GO:0046485) |
| 0.4 |
14.7 |
GO:0050655 |
dermatan sulfate proteoglycan metabolic process(GO:0050655) |
| 0.4 |
0.9 |
GO:0048549 |
positive regulation of pinocytosis(GO:0048549) |
| 0.4 |
0.9 |
GO:0015827 |
tryptophan transport(GO:0015827) |
| 0.4 |
2.2 |
GO:0030382 |
sperm mitochondrion organization(GO:0030382) |
| 0.4 |
3.5 |
GO:1904694 |
negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.4 |
0.4 |
GO:0046882 |
negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
| 0.4 |
3.9 |
GO:0006729 |
tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
| 0.4 |
1.3 |
GO:0000961 |
negative regulation of mitochondrial RNA catabolic process(GO:0000961) |
| 0.4 |
6.5 |
GO:0006751 |
glutathione catabolic process(GO:0006751) |
| 0.4 |
1.3 |
GO:2000620 |
positive regulation of histone H4-K16 acetylation(GO:2000620) |
| 0.4 |
1.7 |
GO:0045650 |
negative regulation of macrophage differentiation(GO:0045650) |
| 0.4 |
0.4 |
GO:0045408 |
regulation of interleukin-6 biosynthetic process(GO:0045408) |
| 0.4 |
3.9 |
GO:0001887 |
selenium compound metabolic process(GO:0001887) |
| 0.4 |
1.7 |
GO:0009298 |
GDP-mannose biosynthetic process(GO:0009298) |
| 0.4 |
0.9 |
GO:0046452 |
dihydrofolate metabolic process(GO:0046452) |
| 0.4 |
0.9 |
GO:0046292 |
formaldehyde metabolic process(GO:0046292) |
| 0.4 |
3.0 |
GO:0006177 |
GMP biosynthetic process(GO:0006177) |
| 0.4 |
4.3 |
GO:0034625 |
fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.4 |
0.4 |
GO:0036090 |
cleavage furrow ingression(GO:0036090) |
| 0.4 |
0.4 |
GO:0048755 |
branching morphogenesis of a nerve(GO:0048755) |
| 0.4 |
49.7 |
GO:0070126 |
mitochondrial translational termination(GO:0070126) |
| 0.4 |
0.4 |
GO:0000212 |
meiotic spindle organization(GO:0000212) |
| 0.4 |
3.4 |
GO:0044375 |
regulation of peroxisome size(GO:0044375) |
| 0.4 |
1.3 |
GO:0016260 |
selenocysteine biosynthetic process(GO:0016260) |
| 0.4 |
0.8 |
GO:0002086 |
diaphragm contraction(GO:0002086) |
| 0.4 |
2.1 |
GO:0018057 |
peptidyl-lysine oxidation(GO:0018057) |
| 0.4 |
2.1 |
GO:0045085 |
negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
| 0.4 |
2.1 |
GO:0008295 |
spermidine biosynthetic process(GO:0008295) |
| 0.4 |
11.7 |
GO:2001044 |
regulation of integrin-mediated signaling pathway(GO:2001044) |
| 0.4 |
1.7 |
GO:0010579 |
regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
| 0.4 |
1.7 |
GO:0007021 |
tubulin complex assembly(GO:0007021) |
| 0.4 |
1.2 |
GO:0046884 |
follicle-stimulating hormone secretion(GO:0046884) |
| 0.4 |
2.5 |
GO:0070269 |
pyroptosis(GO:0070269) |
| 0.4 |
1.7 |
GO:0030885 |
regulation of myeloid dendritic cell activation(GO:0030885) |
| 0.4 |
1.6 |
GO:0006556 |
S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.4 |
0.8 |
GO:0043376 |
regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
| 0.4 |
1.6 |
GO:0050858 |
negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) |
| 0.4 |
1.6 |
GO:0051970 |
negative regulation of transmission of nerve impulse(GO:0051970) |
| 0.4 |
1.2 |
GO:0090258 |
negative regulation of mitochondrial fission(GO:0090258) |
| 0.4 |
2.8 |
GO:0042532 |
negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
| 0.4 |
1.2 |
GO:0070426 |
positive regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070426) positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070434) |
| 0.4 |
0.8 |
GO:0021529 |
spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
| 0.4 |
2.8 |
GO:0019557 |
histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
| 0.4 |
0.4 |
GO:0061091 |
regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
| 0.4 |
11.3 |
GO:0031115 |
negative regulation of microtubule polymerization(GO:0031115) |
| 0.4 |
6.8 |
GO:0071688 |
striated muscle myosin thick filament assembly(GO:0071688) |
| 0.4 |
8.4 |
GO:2000480 |
negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.4 |
0.8 |
GO:1903976 |
negative regulation of glial cell migration(GO:1903976) |
| 0.4 |
8.0 |
GO:0001682 |
tRNA 5'-leader removal(GO:0001682) |
| 0.4 |
2.0 |
GO:0006432 |
phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.4 |
0.8 |
GO:0072229 |
proximal convoluted tubule development(GO:0072019) metanephric proximal convoluted tubule development(GO:0072229) |
| 0.4 |
7.1 |
GO:0034983 |
peptidyl-lysine deacetylation(GO:0034983) |
| 0.4 |
1.6 |
GO:0045917 |
positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
| 0.4 |
6.3 |
GO:0001964 |
startle response(GO:0001964) |
| 0.4 |
0.4 |
GO:1903762 |
positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1903762) positive regulation of ventricular cardiac muscle cell action potential(GO:1903947) positive regulation of membrane repolarization during ventricular cardiac muscle cell action potential(GO:1905026) positive regulation of membrane repolarization during cardiac muscle cell action potential(GO:1905033) |
| 0.4 |
2.7 |
GO:0006975 |
DNA damage induced protein phosphorylation(GO:0006975) |
| 0.4 |
1.2 |
GO:0061537 |
glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
| 0.4 |
1.2 |
GO:0042758 |
long-chain fatty acid catabolic process(GO:0042758) |
| 0.4 |
2.3 |
GO:0032383 |
regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 0.4 |
1.6 |
GO:0015742 |
alpha-ketoglutarate transport(GO:0015742) |
| 0.4 |
36.9 |
GO:0051436 |
negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle(GO:0051436) regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle(GO:0051439) |
| 0.4 |
3.5 |
GO:1901660 |
calcium ion export(GO:1901660) calcium ion export from cell(GO:1990034) |
| 0.4 |
0.8 |
GO:0046968 |
peptide antigen transport(GO:0046968) |
| 0.4 |
1.2 |
GO:0044805 |
late nucleophagy(GO:0044805) |
| 0.4 |
1.5 |
GO:0043418 |
homocysteine catabolic process(GO:0043418) |
| 0.4 |
3.1 |
GO:0055064 |
chloride ion homeostasis(GO:0055064) |
| 0.4 |
3.8 |
GO:0086024 |
adrenergic receptor signaling pathway involved in positive regulation of heart rate(GO:0086024) |
| 0.4 |
5.8 |
GO:0070208 |
protein heterotrimerization(GO:0070208) |
| 0.4 |
9.2 |
GO:0046341 |
CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.4 |
2.7 |
GO:0006517 |
protein deglycosylation(GO:0006517) |
| 0.4 |
0.8 |
GO:0007228 |
positive regulation of hh target transcription factor activity(GO:0007228) |
| 0.4 |
1.1 |
GO:0043353 |
enucleate erythrocyte differentiation(GO:0043353) |
| 0.4 |
0.8 |
GO:0014745 |
negative regulation of muscle adaptation(GO:0014745) regulation of skeletal muscle hypertrophy(GO:1904204) |
| 0.4 |
0.8 |
GO:0002424 |
T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) protein import into mitochondrial intermembrane space(GO:0045041) |
| 0.4 |
1.1 |
GO:0021797 |
forebrain anterior/posterior pattern specification(GO:0021797) |
| 0.4 |
0.8 |
GO:1901722 |
regulation of cell proliferation involved in kidney development(GO:1901722) |
| 0.4 |
2.3 |
GO:0031125 |
rRNA 3'-end processing(GO:0031125) |
| 0.4 |
0.4 |
GO:1904885 |
beta-catenin destruction complex assembly(GO:1904885) |
| 0.4 |
1.1 |
GO:0046166 |
glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 0.4 |
4.5 |
GO:0010739 |
positive regulation of protein kinase A signaling(GO:0010739) |
| 0.4 |
4.5 |
GO:0016075 |
rRNA catabolic process(GO:0016075) |
| 0.4 |
0.4 |
GO:0060137 |
maternal process involved in parturition(GO:0060137) |
| 0.4 |
0.8 |
GO:0050766 |
positive regulation of phagocytosis(GO:0050766) |
| 0.4 |
4.9 |
GO:0035845 |
photoreceptor cell outer segment organization(GO:0035845) |
| 0.4 |
1.1 |
GO:0033386 |
geranylgeranyl diphosphate metabolic process(GO:0033385) geranylgeranyl diphosphate biosynthetic process(GO:0033386) |
| 0.4 |
4.8 |
GO:0090385 |
phagosome-lysosome fusion(GO:0090385) |
| 0.4 |
2.2 |
GO:1900748 |
positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 0.4 |
1.5 |
GO:0045208 |
MAPK phosphatase export from nucleus(GO:0045208) MAPK phosphatase export from nucleus, leptomycin B sensitive(GO:0045209) |
| 0.4 |
1.9 |
GO:0043950 |
positive regulation of cAMP-mediated signaling(GO:0043950) |
| 0.4 |
3.3 |
GO:0071786 |
endoplasmic reticulum tubular network organization(GO:0071786) |
| 0.4 |
2.2 |
GO:0006651 |
diacylglycerol biosynthetic process(GO:0006651) |
| 0.4 |
4.4 |
GO:0032780 |
negative regulation of ATPase activity(GO:0032780) |
| 0.4 |
0.7 |
GO:0031293 |
membrane protein intracellular domain proteolysis(GO:0031293) |
| 0.4 |
5.5 |
GO:0070129 |
regulation of mitochondrial translation(GO:0070129) |
| 0.4 |
0.4 |
GO:0090212 |
regulation of establishment of blood-brain barrier(GO:0090210) negative regulation of establishment of blood-brain barrier(GO:0090212) |
| 0.4 |
1.1 |
GO:0071163 |
DNA replication preinitiation complex assembly(GO:0071163) |
| 0.4 |
0.4 |
GO:1903433 |
regulation of constitutive secretory pathway(GO:1903433) |
| 0.4 |
8.4 |
GO:0007220 |
Notch receptor processing(GO:0007220) |
| 0.4 |
1.1 |
GO:0060075 |
regulation of resting membrane potential(GO:0060075) |
| 0.4 |
9.5 |
GO:0090022 |
regulation of neutrophil chemotaxis(GO:0090022) |
| 0.4 |
1.8 |
GO:0061469 |
regulation of type B pancreatic cell proliferation(GO:0061469) |
| 0.4 |
0.4 |
GO:2000584 |
regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000583) negative regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000584) |
| 0.4 |
2.5 |
GO:0006572 |
tyrosine catabolic process(GO:0006572) |
| 0.4 |
3.3 |
GO:0090656 |
t-circle formation(GO:0090656) |
| 0.4 |
1.1 |
GO:0021936 |
regulation of cerebellar granule cell precursor proliferation(GO:0021936) |
| 0.4 |
2.9 |
GO:0019748 |
secondary metabolic process(GO:0019748) |
| 0.4 |
2.2 |
GO:0086046 |
membrane depolarization during SA node cell action potential(GO:0086046) |
| 0.4 |
8.6 |
GO:0051014 |
actin filament severing(GO:0051014) |
| 0.4 |
1.1 |
GO:0042832 |
defense response to protozoan(GO:0042832) |
| 0.4 |
1.1 |
GO:0061580 |
colon epithelial cell migration(GO:0061580) |
| 0.4 |
1.8 |
GO:1901898 |
negative regulation of relaxation of muscle(GO:1901078) negative regulation of relaxation of cardiac muscle(GO:1901898) |
| 0.4 |
0.7 |
GO:0032971 |
regulation of muscle filament sliding(GO:0032971) |
| 0.4 |
5.0 |
GO:1904322 |
response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 0.4 |
4.6 |
GO:0006824 |
cobalt ion transport(GO:0006824) |
| 0.4 |
7.1 |
GO:0000338 |
protein deneddylation(GO:0000338) |
| 0.4 |
1.1 |
GO:0021812 |
neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 0.4 |
1.1 |
GO:0006667 |
sphinganine metabolic process(GO:0006667) |
| 0.4 |
6.7 |
GO:2000096 |
positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
| 0.3 |
2.4 |
GO:0010133 |
proline catabolic process(GO:0006562) proline catabolic process to glutamate(GO:0010133) |
| 0.3 |
15.4 |
GO:0036297 |
interstrand cross-link repair(GO:0036297) |
| 0.3 |
1.0 |
GO:0036451 |
cap mRNA methylation(GO:0036451) |
| 0.3 |
0.3 |
GO:0007185 |
transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
| 0.3 |
3.1 |
GO:0061179 |
negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.3 |
2.8 |
GO:0031119 |
tRNA pseudouridine synthesis(GO:0031119) |
| 0.3 |
3.5 |
GO:0042983 |
amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
| 0.3 |
0.3 |
GO:1903336 |
negative regulation of vacuolar transport(GO:1903336) |
| 0.3 |
0.3 |
GO:0044650 |
virion attachment to host cell(GO:0019062) adhesion of symbiont to host cell(GO:0044650) receptor-mediated virion attachment to host cell(GO:0046813) |
| 0.3 |
4.1 |
GO:0031936 |
negative regulation of chromatin silencing(GO:0031936) |
| 0.3 |
1.0 |
GO:0042450 |
arginine biosynthetic process via ornithine(GO:0042450) |
| 0.3 |
3.1 |
GO:1903361 |
protein localization to basolateral plasma membrane(GO:1903361) |
| 0.3 |
2.1 |
GO:0060263 |
regulation of respiratory burst(GO:0060263) |
| 0.3 |
1.4 |
GO:0033615 |
mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
| 0.3 |
30.8 |
GO:0032981 |
NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.3 |
1.7 |
GO:1902775 |
mitochondrial ribosome assembly(GO:0061668) mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.3 |
0.3 |
GO:0002034 |
regulation of blood vessel size by renin-angiotensin(GO:0002034) renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure(GO:0003072) |
| 0.3 |
1.4 |
GO:0090219 |
negative regulation of lipid kinase activity(GO:0090219) |
| 0.3 |
1.4 |
GO:0097411 |
hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.3 |
0.7 |
GO:0012502 |
induction of programmed cell death(GO:0012502) positive regulation of apoptotic process in other organism(GO:0044533) positive regulation by symbiont of host programmed cell death(GO:0052042) positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052330) positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052501) |
| 0.3 |
1.0 |
GO:1900098 |
epithelial cell differentiation involved in salivary gland development(GO:0060690) epithelial cell maturation involved in salivary gland development(GO:0060691) regulation of plasma cell differentiation(GO:1900098) positive regulation of plasma cell differentiation(GO:1900100) regulation of lactation(GO:1903487) positive regulation of lactation(GO:1903489) |
| 0.3 |
6.4 |
GO:0006198 |
cAMP catabolic process(GO:0006198) |
| 0.3 |
1.3 |
GO:0044240 |
multicellular organism lipid catabolic process(GO:0044240) |
| 0.3 |
9.0 |
GO:0007625 |
grooming behavior(GO:0007625) |
| 0.3 |
1.7 |
GO:0019323 |
pentose catabolic process(GO:0019323) |
| 0.3 |
0.3 |
GO:1905005 |
regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905005) |
| 0.3 |
0.3 |
GO:0061152 |
trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
| 0.3 |
4.3 |
GO:0006621 |
protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
| 0.3 |
0.7 |
GO:0036146 |
cellular response to mycotoxin(GO:0036146) |
| 0.3 |
1.0 |
GO:0051919 |
positive regulation of fibrinolysis(GO:0051919) |
| 0.3 |
0.3 |
GO:1904294 |
positive regulation of ERAD pathway(GO:1904294) |
| 0.3 |
2.0 |
GO:0045003 |
DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
| 0.3 |
0.7 |
GO:1902309 |
negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
| 0.3 |
0.7 |
GO:0006559 |
L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
| 0.3 |
1.0 |
GO:0099552 |
trans-synaptic signaling by lipid, modulating synaptic transmission(GO:0099552) trans-synaptic signaling by endocannabinoid, modulating synaptic transmission(GO:0099553) |
| 0.3 |
2.6 |
GO:0045636 |
positive regulation of melanocyte differentiation(GO:0045636) |
| 0.3 |
0.7 |
GO:0010455 |
positive regulation of cell fate commitment(GO:0010455) |
| 0.3 |
2.6 |
GO:0034472 |
snRNA 3'-end processing(GO:0034472) |
| 0.3 |
1.6 |
GO:0061031 |
endodermal digestive tract morphogenesis(GO:0061031) |
| 0.3 |
0.6 |
GO:0060080 |
inhibitory postsynaptic potential(GO:0060080) |
| 0.3 |
8.1 |
GO:0030261 |
chromosome condensation(GO:0030261) |
| 0.3 |
1.3 |
GO:0021849 |
neuroblast division in subventricular zone(GO:0021849) |
| 0.3 |
1.6 |
GO:0042357 |
thiamine diphosphate metabolic process(GO:0042357) |
| 0.3 |
2.9 |
GO:0010459 |
negative regulation of heart rate(GO:0010459) |
| 0.3 |
1.9 |
GO:0036123 |
histone H3-K9 dimethylation(GO:0036123) |
| 0.3 |
1.6 |
GO:1902626 |
assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.3 |
1.0 |
GO:0001777 |
T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
| 0.3 |
1.9 |
GO:1904706 |
negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
| 0.3 |
1.0 |
GO:1902630 |
regulation of membrane hyperpolarization(GO:1902630) |
| 0.3 |
2.5 |
GO:0044565 |
dendritic cell proliferation(GO:0044565) |
| 0.3 |
1.9 |
GO:0045792 |
negative regulation of cell size(GO:0045792) |
| 0.3 |
4.1 |
GO:2000766 |
negative regulation of cytoplasmic translation(GO:2000766) |
| 0.3 |
1.6 |
GO:1900273 |
positive regulation of long-term synaptic potentiation(GO:1900273) |
| 0.3 |
0.6 |
GO:0060261 |
positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
| 0.3 |
0.9 |
GO:0015680 |
intracellular copper ion transport(GO:0015680) |
| 0.3 |
0.9 |
GO:0043931 |
ossification involved in bone maturation(GO:0043931) |
| 0.3 |
0.3 |
GO:0008343 |
adult feeding behavior(GO:0008343) |
| 0.3 |
0.9 |
GO:0002940 |
tRNA N2-guanine methylation(GO:0002940) |
| 0.3 |
4.0 |
GO:0010764 |
negative regulation of fibroblast migration(GO:0010764) |
| 0.3 |
0.6 |
GO:1990314 |
cellular response to insulin-like growth factor stimulus(GO:1990314) |
| 0.3 |
7.4 |
GO:0021517 |
ventral spinal cord development(GO:0021517) |
| 0.3 |
5.2 |
GO:0045880 |
positive regulation of smoothened signaling pathway(GO:0045880) |
| 0.3 |
1.5 |
GO:0097577 |
intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
| 0.3 |
1.2 |
GO:0042144 |
vacuole fusion, non-autophagic(GO:0042144) |
| 0.3 |
4.6 |
GO:0001675 |
acrosome assembly(GO:0001675) |
| 0.3 |
1.2 |
GO:0044339 |
canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
| 0.3 |
0.6 |
GO:0045360 |
regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) |
| 0.3 |
0.6 |
GO:0016322 |
neuron remodeling(GO:0016322) |
| 0.3 |
0.6 |
GO:0042760 |
very long-chain fatty acid catabolic process(GO:0042760) |
| 0.3 |
0.9 |
GO:0060743 |
epithelial cell maturation involved in prostate gland development(GO:0060743) |
| 0.3 |
0.3 |
GO:0033686 |
positive regulation of luteinizing hormone secretion(GO:0033686) |
| 0.3 |
5.1 |
GO:0034356 |
NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
| 0.3 |
1.2 |
GO:0050712 |
negative regulation of interleukin-1 alpha production(GO:0032690) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
| 0.3 |
6.3 |
GO:1904152 |
regulation of retrograde protein transport, ER to cytosol(GO:1904152) |
| 0.3 |
1.5 |
GO:0060010 |
Sertoli cell fate commitment(GO:0060010) |
| 0.3 |
0.9 |
GO:0032877 |
positive regulation of DNA endoreduplication(GO:0032877) |
| 0.3 |
1.5 |
GO:0098935 |
dendritic transport(GO:0098935) anterograde dendritic transport(GO:0098937) |
| 0.3 |
0.6 |
GO:0043653 |
mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
| 0.3 |
0.6 |
GO:1903436 |
regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
| 0.3 |
1.2 |
GO:0098795 |
mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
| 0.3 |
2.9 |
GO:0034162 |
toll-like receptor 9 signaling pathway(GO:0034162) |
| 0.3 |
1.7 |
GO:2000193 |
positive regulation of icosanoid secretion(GO:0032305) positive regulation of fatty acid transport(GO:2000193) |
| 0.3 |
1.4 |
GO:0044208 |
'de novo' AMP biosynthetic process(GO:0044208) |
| 0.3 |
0.6 |
GO:0032229 |
negative regulation of synaptic transmission, GABAergic(GO:0032229) |
| 0.3 |
0.3 |
GO:0060922 |
cardiac septum cell differentiation(GO:0003292) atrioventricular node cell differentiation(GO:0060922) atrioventricular node cell development(GO:0060928) |
| 0.3 |
2.3 |
GO:0051725 |
protein de-ADP-ribosylation(GO:0051725) |
| 0.3 |
3.7 |
GO:0045956 |
positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
| 0.3 |
5.4 |
GO:0030322 |
stabilization of membrane potential(GO:0030322) |
| 0.3 |
0.6 |
GO:0051792 |
medium-chain fatty acid biosynthetic process(GO:0051792) |
| 0.3 |
1.1 |
GO:0035754 |
B cell chemotaxis(GO:0035754) |
| 0.3 |
3.4 |
GO:0090235 |
regulation of metaphase plate congression(GO:0090235) |
| 0.3 |
0.8 |
GO:0071418 |
cellular response to amine stimulus(GO:0071418) |
| 0.3 |
0.8 |
GO:1901723 |
negative regulation of cell proliferation involved in kidney development(GO:1901723) |
| 0.3 |
2.0 |
GO:1900193 |
regulation of oocyte maturation(GO:1900193) |
| 0.3 |
3.9 |
GO:0070072 |
proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 0.3 |
1.1 |
GO:0002572 |
pro-T cell differentiation(GO:0002572) |
| 0.3 |
4.5 |
GO:0006388 |
tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.3 |
0.8 |
GO:0050703 |
interleukin-1 alpha production(GO:0032610) interleukin-1 alpha secretion(GO:0050703) |
| 0.3 |
0.6 |
GO:0034316 |
negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
| 0.3 |
1.7 |
GO:0090154 |
positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
| 0.3 |
0.3 |
GO:0001757 |
somite specification(GO:0001757) |
| 0.3 |
4.4 |
GO:1990118 |
sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 0.3 |
1.4 |
GO:0003062 |
regulation of heart rate by chemical signal(GO:0003062) |
| 0.3 |
0.8 |
GO:0042135 |
neurotransmitter catabolic process(GO:0042135) |
| 0.3 |
9.1 |
GO:0000462 |
maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
| 0.3 |
1.6 |
GO:0033668 |
negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
| 0.3 |
1.4 |
GO:0045617 |
negative regulation of keratinocyte differentiation(GO:0045617) |
| 0.3 |
0.8 |
GO:2000001 |
regulation of DNA damage checkpoint(GO:2000001) |
| 0.3 |
0.8 |
GO:0010898 |
positive regulation of triglyceride catabolic process(GO:0010898) |
| 0.3 |
2.2 |
GO:0019236 |
response to pheromone(GO:0019236) |
| 0.3 |
6.2 |
GO:0006957 |
complement activation, alternative pathway(GO:0006957) |
| 0.3 |
1.6 |
GO:0061298 |
retina vasculature development in camera-type eye(GO:0061298) |
| 0.3 |
0.3 |
GO:1904862 |
inhibitory synapse assembly(GO:1904862) |
| 0.3 |
1.9 |
GO:0045922 |
negative regulation of fatty acid metabolic process(GO:0045922) |
| 0.3 |
1.1 |
GO:1990523 |
bone regeneration(GO:1990523) |
| 0.3 |
0.8 |
GO:1902804 |
negative regulation of synaptic vesicle transport(GO:1902804) |
| 0.3 |
0.5 |
GO:1904031 |
positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
| 0.3 |
0.8 |
GO:0035425 |
autocrine signaling(GO:0035425) |
| 0.3 |
1.3 |
GO:0090164 |
asymmetric Golgi ribbon formation(GO:0090164) |
| 0.3 |
3.2 |
GO:1901571 |
icosanoid transport(GO:0071715) fatty acid derivative transport(GO:1901571) |
| 0.3 |
1.3 |
GO:0045065 |
cytotoxic T cell differentiation(GO:0045065) |
| 0.3 |
0.8 |
GO:0002426 |
immunoglobulin production in mucosal tissue(GO:0002426) |
| 0.3 |
0.8 |
GO:0006419 |
alanyl-tRNA aminoacylation(GO:0006419) |
| 0.3 |
1.3 |
GO:0098532 |
histone H3-K27 trimethylation(GO:0098532) |
| 0.3 |
3.7 |
GO:0030238 |
male sex determination(GO:0030238) |
| 0.3 |
0.8 |
GO:0014022 |
neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
| 0.3 |
0.8 |
GO:0070901 |
mitochondrial tRNA methylation(GO:0070901) |
| 0.3 |
2.1 |
GO:1901142 |
insulin metabolic process(GO:1901142) |
| 0.3 |
4.2 |
GO:0036376 |
sodium ion export from cell(GO:0036376) |
| 0.3 |
0.5 |
GO:0090076 |
relaxation of skeletal muscle(GO:0090076) |
| 0.3 |
1.0 |
GO:0009236 |
cobalamin biosynthetic process(GO:0009236) |
| 0.3 |
3.1 |
GO:0018214 |
peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
| 0.3 |
1.6 |
GO:0070358 |
actin polymerization-dependent cell motility(GO:0070358) |
| 0.3 |
13.5 |
GO:0006904 |
vesicle docking involved in exocytosis(GO:0006904) |
| 0.3 |
10.9 |
GO:0035428 |
hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
| 0.3 |
2.6 |
GO:0002943 |
tRNA dihydrouridine synthesis(GO:0002943) |
| 0.3 |
0.3 |
GO:0002314 |
germinal center B cell differentiation(GO:0002314) |
| 0.3 |
1.0 |
GO:0045897 |
positive regulation of transcription during mitosis(GO:0045897) |
| 0.3 |
0.8 |
GO:1902410 |
mitotic cytokinetic process(GO:1902410) |
| 0.3 |
1.0 |
GO:0046967 |
cytosol to ER transport(GO:0046967) |
| 0.3 |
0.8 |
GO:0050822 |
peptide stabilization(GO:0050822) peptide antigen stabilization(GO:0050823) |
| 0.3 |
7.6 |
GO:0071577 |
zinc II ion transmembrane transport(GO:0071577) |
| 0.3 |
4.6 |
GO:0044130 |
negative regulation of growth of symbiont in host(GO:0044130) |
| 0.3 |
0.8 |
GO:0009648 |
photoperiodism(GO:0009648) |
| 0.3 |
1.0 |
GO:0035624 |
receptor transactivation(GO:0035624) |
| 0.3 |
0.8 |
GO:1903564 |
regulation of protein localization to cilium(GO:1903564) |
| 0.3 |
0.8 |
GO:1903748 |
negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
| 0.3 |
3.3 |
GO:0018095 |
protein polyglutamylation(GO:0018095) |
| 0.3 |
0.5 |
GO:0031536 |
positive regulation of exit from mitosis(GO:0031536) |
| 0.2 |
0.7 |
GO:0006427 |
histidyl-tRNA aminoacylation(GO:0006427) |
| 0.2 |
0.5 |
GO:1904017 |
cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
| 0.2 |
0.5 |
GO:0030240 |
skeletal myofibril assembly(GO:0014866) skeletal muscle thin filament assembly(GO:0030240) |
| 0.2 |
0.2 |
GO:0019605 |
butyrate metabolic process(GO:0019605) |
| 0.2 |
1.0 |
GO:0060478 |
acrosomal vesicle exocytosis(GO:0060478) |
| 0.2 |
1.5 |
GO:0042271 |
susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
| 0.2 |
1.7 |
GO:0048165 |
ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
| 0.2 |
5.6 |
GO:0034643 |
establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
| 0.2 |
2.9 |
GO:0035493 |
SNARE complex assembly(GO:0035493) |
| 0.2 |
1.5 |
GO:0040016 |
embryonic cleavage(GO:0040016) |
| 0.2 |
2.7 |
GO:2000310 |
regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
| 0.2 |
12.8 |
GO:0061620 |
glycolytic process through fructose-6-phosphate(GO:0061615) glycolytic process through glucose-6-phosphate(GO:0061620) |
| 0.2 |
0.5 |
GO:0055089 |
fatty acid homeostasis(GO:0055089) |
| 0.2 |
1.2 |
GO:0001315 |
age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
| 0.2 |
6.3 |
GO:0072662 |
protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
| 0.2 |
2.2 |
GO:0035641 |
locomotory exploration behavior(GO:0035641) |
| 0.2 |
2.6 |
GO:0070934 |
CRD-mediated mRNA stabilization(GO:0070934) |
| 0.2 |
1.0 |
GO:0015732 |
prostaglandin transport(GO:0015732) |
| 0.2 |
0.2 |
GO:0010796 |
regulation of multivesicular body size(GO:0010796) |
| 0.2 |
4.7 |
GO:2001135 |
regulation of endocytic recycling(GO:2001135) |
| 0.2 |
1.4 |
GO:0061051 |
positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
| 0.2 |
1.9 |
GO:0030007 |
cellular potassium ion homeostasis(GO:0030007) |
| 0.2 |
0.9 |
GO:0071462 |
cellular response to water deprivation(GO:0042631) cellular response to water stimulus(GO:0071462) |
| 0.2 |
1.6 |
GO:0021877 |
forebrain neuron fate commitment(GO:0021877) |
| 0.2 |
0.2 |
GO:0060167 |
regulation of adenosine receptor signaling pathway(GO:0060167) |
| 0.2 |
0.2 |
GO:0043379 |
memory T cell differentiation(GO:0043379) |
| 0.2 |
0.7 |
GO:0070365 |
hepatocyte differentiation(GO:0070365) |
| 0.2 |
0.7 |
GO:0042416 |
dopamine biosynthetic process(GO:0042416) |
| 0.2 |
0.2 |
GO:0021895 |
cerebral cortex neuron differentiation(GO:0021895) |
| 0.2 |
0.5 |
GO:0006425 |
glutaminyl-tRNA aminoacylation(GO:0006425) |
| 0.2 |
1.4 |
GO:1901386 |
negative regulation of voltage-gated calcium channel activity(GO:1901386) |
| 0.2 |
1.1 |
GO:0000738 |
DNA catabolic process, exonucleolytic(GO:0000738) |
| 0.2 |
3.0 |
GO:1901385 |
regulation of voltage-gated calcium channel activity(GO:1901385) |
| 0.2 |
0.2 |
GO:0071468 |
cellular response to acidic pH(GO:0071468) |
| 0.2 |
0.7 |
GO:0034343 |
type III interferon production(GO:0034343) regulation of type III interferon production(GO:0034344) |
| 0.2 |
1.1 |
GO:0010040 |
response to iron(II) ion(GO:0010040) |
| 0.2 |
0.7 |
GO:0009206 |
purine ribonucleoside triphosphate biosynthetic process(GO:0009206) |
| 0.2 |
0.7 |
GO:0051534 |
negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.2 |
1.8 |
GO:0006013 |
mannose metabolic process(GO:0006013) |
| 0.2 |
2.5 |
GO:0042118 |
endothelial cell activation(GO:0042118) |
| 0.2 |
0.5 |
GO:0000706 |
meiotic DNA double-strand break processing(GO:0000706) double-strand break repair involved in meiotic recombination(GO:1990918) |
| 0.2 |
2.5 |
GO:0018202 |
peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
| 0.2 |
2.2 |
GO:0048291 |
isotype switching to IgG isotypes(GO:0048291) |
| 0.2 |
0.7 |
GO:0001302 |
replicative cell aging(GO:0001302) |
| 0.2 |
2.2 |
GO:0018065 |
protein-cofactor linkage(GO:0018065) |
| 0.2 |
1.8 |
GO:0021555 |
midbrain-hindbrain boundary morphogenesis(GO:0021555) |
| 0.2 |
0.9 |
GO:0071712 |
ER-associated misfolded protein catabolic process(GO:0071712) |
| 0.2 |
0.4 |
GO:2001302 |
lipoxin biosynthetic process(GO:2001301) lipoxin A4 metabolic process(GO:2001302) lipoxin A4 biosynthetic process(GO:2001303) |
| 0.2 |
0.7 |
GO:0071529 |
cementum mineralization(GO:0071529) |
| 0.2 |
0.7 |
GO:0021569 |
rhombomere 3 development(GO:0021569) |
| 0.2 |
1.3 |
GO:0006420 |
arginyl-tRNA aminoacylation(GO:0006420) |
| 0.2 |
0.7 |
GO:0010728 |
regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
| 0.2 |
0.2 |
GO:0035470 |
positive regulation of vascular wound healing(GO:0035470) |
| 0.2 |
0.4 |
GO:2000255 |
negative regulation of male germ cell proliferation(GO:2000255) |
| 0.2 |
0.9 |
GO:0036378 |
calcitriol biosynthetic process from calciol(GO:0036378) |
| 0.2 |
2.2 |
GO:0045793 |
positive regulation of cell size(GO:0045793) |
| 0.2 |
0.4 |
GO:0019417 |
sulfur oxidation(GO:0019417) |
| 0.2 |
0.7 |
GO:0008216 |
spermidine metabolic process(GO:0008216) |
| 0.2 |
0.9 |
GO:0010960 |
magnesium ion homeostasis(GO:0010960) |
| 0.2 |
0.2 |
GO:0032364 |
oxygen homeostasis(GO:0032364) |
| 0.2 |
0.2 |
GO:0044828 |
negative regulation by host of viral process(GO:0044793) negative regulation by host of viral genome replication(GO:0044828) |
| 0.2 |
0.9 |
GO:0034755 |
iron ion transmembrane transport(GO:0034755) |
| 0.2 |
3.5 |
GO:0033689 |
negative regulation of osteoblast proliferation(GO:0033689) |
| 0.2 |
1.5 |
GO:0046716 |
muscle cell cellular homeostasis(GO:0046716) |
| 0.2 |
0.9 |
GO:0006500 |
N-terminal protein palmitoylation(GO:0006500) |
| 0.2 |
0.2 |
GO:0010636 |
positive regulation of mitochondrial fusion(GO:0010636) |
| 0.2 |
0.4 |
GO:0033140 |
negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
| 0.2 |
1.7 |
GO:0070493 |
thrombin receptor signaling pathway(GO:0070493) |
| 0.2 |
3.0 |
GO:0071397 |
cellular response to cholesterol(GO:0071397) |
| 0.2 |
4.1 |
GO:0036109 |
alpha-linolenic acid metabolic process(GO:0036109) |
| 0.2 |
0.4 |
GO:0044691 |
tooth eruption(GO:0044691) |
| 0.2 |
0.9 |
GO:0043490 |
malate-aspartate shuttle(GO:0043490) |
| 0.2 |
0.4 |
GO:0033148 |
positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 0.2 |
0.4 |
GO:0051315 |
attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
| 0.2 |
3.4 |
GO:0019371 |
cyclooxygenase pathway(GO:0019371) |
| 0.2 |
1.7 |
GO:0006537 |
glutamate biosynthetic process(GO:0006537) |
| 0.2 |
0.6 |
GO:0090260 |
filtration diaphragm assembly(GO:0036058) slit diaphragm assembly(GO:0036060) negative regulation of retinal ganglion cell axon guidance(GO:0090260) |
| 0.2 |
1.5 |
GO:0006616 |
SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
| 0.2 |
0.4 |
GO:0009786 |
regulation of asymmetric cell division(GO:0009786) |
| 0.2 |
0.2 |
GO:0060353 |
regulation of cell adhesion molecule production(GO:0060353) |
| 0.2 |
1.9 |
GO:0000395 |
mRNA 5'-splice site recognition(GO:0000395) |
| 0.2 |
0.2 |
GO:0044273 |
sulfur compound catabolic process(GO:0044273) |
| 0.2 |
0.8 |
GO:0065001 |
specification of axis polarity(GO:0065001) |
| 0.2 |
0.8 |
GO:0015688 |
iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
| 0.2 |
0.6 |
GO:0032203 |
telomere formation via telomerase(GO:0032203) |
| 0.2 |
1.6 |
GO:0006348 |
chromatin silencing at telomere(GO:0006348) |
| 0.2 |
2.5 |
GO:0016554 |
cytidine to uridine editing(GO:0016554) |
| 0.2 |
17.1 |
GO:0008033 |
tRNA processing(GO:0008033) |
| 0.2 |
0.4 |
GO:0045541 |
negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
| 0.2 |
0.6 |
GO:1901340 |
negative regulation of store-operated calcium channel activity(GO:1901340) |
| 0.2 |
0.2 |
GO:0018342 |
protein prenylation(GO:0018342) prenylation(GO:0097354) |
| 0.2 |
0.8 |
GO:0070672 |
response to interleukin-15(GO:0070672) |
| 0.2 |
1.0 |
GO:0002154 |
thyroid hormone mediated signaling pathway(GO:0002154) regulation of thyroid hormone mediated signaling pathway(GO:0002155) kinin cascade(GO:0002254) plasma kallikrein-kinin cascade(GO:0002353) |
| 0.2 |
2.0 |
GO:0006346 |
methylation-dependent chromatin silencing(GO:0006346) |
| 0.2 |
1.2 |
GO:0051001 |
negative regulation of nitric-oxide synthase activity(GO:0051001) |
| 0.2 |
0.2 |
GO:0002663 |
B cell tolerance induction(GO:0002514) regulation of B cell tolerance induction(GO:0002661) positive regulation of B cell tolerance induction(GO:0002663) |
| 0.2 |
1.8 |
GO:1903818 |
positive regulation of voltage-gated potassium channel activity(GO:1903818) |
| 0.2 |
1.8 |
GO:0043949 |
regulation of cAMP-mediated signaling(GO:0043949) |
| 0.2 |
1.6 |
GO:0071550 |
death-inducing signaling complex assembly(GO:0071550) |
| 0.2 |
0.6 |
GO:0002606 |
positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
| 0.2 |
6.9 |
GO:0015986 |
energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 0.2 |
4.3 |
GO:2000251 |
positive regulation of actin cytoskeleton reorganization(GO:2000251) |
| 0.2 |
0.4 |
GO:0035166 |
post-embryonic hemopoiesis(GO:0035166) |
| 0.2 |
1.4 |
GO:0010499 |
proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.2 |
1.6 |
GO:0006069 |
ethanol oxidation(GO:0006069) |
| 0.2 |
0.2 |
GO:1902214 |
regulation of interleukin-4-mediated signaling pathway(GO:1902214) |
| 0.2 |
2.3 |
GO:0060155 |
platelet dense granule organization(GO:0060155) |
| 0.2 |
0.6 |
GO:0014826 |
vein smooth muscle contraction(GO:0014826) |
| 0.2 |
6.2 |
GO:0001580 |
detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
| 0.2 |
0.6 |
GO:0072757 |
cellular response to camptothecin(GO:0072757) |
| 0.2 |
0.2 |
GO:1904338 |
regulation of dopaminergic neuron differentiation(GO:1904338) |
| 0.2 |
3.3 |
GO:0043578 |
nuclear matrix organization(GO:0043578) |
| 0.2 |
1.9 |
GO:0048266 |
behavioral response to pain(GO:0048266) |
| 0.2 |
0.8 |
GO:1900063 |
regulation of peroxisome organization(GO:1900063) |
| 0.2 |
4.0 |
GO:0010804 |
negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
| 0.2 |
7.1 |
GO:0045737 |
positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
| 0.2 |
1.0 |
GO:0030242 |
pexophagy(GO:0030242) |
| 0.2 |
0.8 |
GO:0019626 |
short-chain fatty acid catabolic process(GO:0019626) |
| 0.2 |
5.2 |
GO:0070207 |
protein homotrimerization(GO:0070207) |
| 0.2 |
1.0 |
GO:0038110 |
interleukin-2-mediated signaling pathway(GO:0038110) |
| 0.2 |
1.3 |
GO:0043382 |
positive regulation of memory T cell differentiation(GO:0043382) |
| 0.2 |
1.7 |
GO:0017196 |
N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.2 |
1.1 |
GO:0061732 |
mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
| 0.2 |
2.6 |
GO:0061577 |
calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
| 0.2 |
2.6 |
GO:0019695 |
choline metabolic process(GO:0019695) |
| 0.2 |
0.8 |
GO:0048312 |
intracellular distribution of mitochondria(GO:0048312) |
| 0.2 |
0.6 |
GO:2000252 |
negative regulation of feeding behavior(GO:2000252) |
| 0.2 |
1.9 |
GO:0007080 |
mitotic metaphase plate congression(GO:0007080) |
| 0.2 |
14.3 |
GO:0007218 |
neuropeptide signaling pathway(GO:0007218) |
| 0.2 |
6.0 |
GO:0043011 |
myeloid dendritic cell differentiation(GO:0043011) |
| 0.2 |
0.2 |
GO:0018206 |
peptidyl-methionine modification(GO:0018206) |
| 0.2 |
7.9 |
GO:0070286 |
axonemal dynein complex assembly(GO:0070286) |
| 0.2 |
2.1 |
GO:0015939 |
pantothenate metabolic process(GO:0015939) |
| 0.2 |
0.9 |
GO:0060316 |
positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
| 0.2 |
9.7 |
GO:0051225 |
spindle assembly(GO:0051225) |
| 0.2 |
0.6 |
GO:0002024 |
diet induced thermogenesis(GO:0002024) |
| 0.2 |
2.6 |
GO:0031340 |
positive regulation of vesicle fusion(GO:0031340) |
| 0.2 |
0.6 |
GO:1900126 |
negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 0.2 |
0.7 |
GO:1901491 |
negative regulation of lymphangiogenesis(GO:1901491) |
| 0.2 |
0.9 |
GO:0045078 |
positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
| 0.2 |
1.3 |
GO:0052203 |
modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
| 0.2 |
0.5 |
GO:2000855 |
mineralocorticoid secretion(GO:0035931) aldosterone secretion(GO:0035932) regulation of mineralocorticoid secretion(GO:2000855) regulation of aldosterone secretion(GO:2000858) |
| 0.2 |
0.5 |
GO:0003228 |
atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
| 0.2 |
0.9 |
GO:0036115 |
fatty-acyl-CoA catabolic process(GO:0036115) |
| 0.2 |
0.2 |
GO:0001743 |
optic placode formation(GO:0001743) |
| 0.2 |
0.4 |
GO:0051967 |
negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 0.2 |
1.1 |
GO:0018032 |
protein amidation(GO:0018032) |
| 0.2 |
0.4 |
GO:0032099 |
negative regulation of response to food(GO:0032096) negative regulation of appetite(GO:0032099) |
| 0.2 |
0.5 |
GO:0051342 |
regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
| 0.2 |
2.9 |
GO:0032411 |
positive regulation of transporter activity(GO:0032411) |
| 0.2 |
1.1 |
GO:0042494 |
detection of bacterial lipoprotein(GO:0042494) |
| 0.2 |
0.2 |
GO:0086053 |
AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
| 0.2 |
2.7 |
GO:0014889 |
muscle atrophy(GO:0014889) |
| 0.2 |
1.6 |
GO:0009214 |
cyclic nucleotide catabolic process(GO:0009214) |
| 0.2 |
0.7 |
GO:0010571 |
positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
| 0.2 |
1.2 |
GO:0051388 |
positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
| 0.2 |
3.5 |
GO:0070886 |
positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
| 0.2 |
0.7 |
GO:0019373 |
epoxygenase P450 pathway(GO:0019373) |
| 0.2 |
1.1 |
GO:0061113 |
pancreas morphogenesis(GO:0061113) |
| 0.2 |
1.9 |
GO:0015671 |
oxygen transport(GO:0015671) |
| 0.2 |
0.9 |
GO:0018262 |
isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
| 0.2 |
1.6 |
GO:0097398 |
response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
| 0.2 |
0.7 |
GO:0042989 |
sequestering of actin monomers(GO:0042989) |
| 0.2 |
0.3 |
GO:0099563 |
modification of synaptic structure(GO:0099563) |
| 0.2 |
0.7 |
GO:0010961 |
cellular magnesium ion homeostasis(GO:0010961) |
| 0.2 |
0.3 |
GO:0031584 |
activation of phospholipase D activity(GO:0031584) |
| 0.2 |
1.9 |
GO:0007351 |
tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
| 0.2 |
12.6 |
GO:0048791 |
calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 0.2 |
0.3 |
GO:0060994 |
regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
| 0.2 |
0.2 |
GO:0032290 |
peripheral nervous system myelin formation(GO:0032290) |
| 0.2 |
0.5 |
GO:0010956 |
negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) |
| 0.2 |
0.2 |
GO:0046416 |
D-amino acid metabolic process(GO:0046416) |
| 0.2 |
10.8 |
GO:0006414 |
translational elongation(GO:0006414) |
| 0.2 |
1.2 |
GO:0042940 |
D-amino acid transport(GO:0042940) |
| 0.2 |
1.3 |
GO:0051450 |
myoblast proliferation(GO:0051450) |
| 0.2 |
0.7 |
GO:2001199 |
negative regulation of dendritic cell differentiation(GO:2001199) |
| 0.2 |
0.3 |
GO:0048769 |
sarcomerogenesis(GO:0048769) |
| 0.2 |
0.5 |
GO:0019064 |
fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
| 0.2 |
1.2 |
GO:2000678 |
negative regulation of transcription regulatory region DNA binding(GO:2000678) |
| 0.2 |
0.7 |
GO:0045872 |
positive regulation of rhodopsin gene expression(GO:0045872) |
| 0.2 |
0.8 |
GO:0043686 |
co-translational protein modification(GO:0043686) |
| 0.2 |
0.5 |
GO:0010756 |
positive regulation of plasminogen activation(GO:0010756) |
| 0.2 |
0.5 |
GO:1903301 |
positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
| 0.2 |
0.7 |
GO:0045722 |
positive regulation of gluconeogenesis(GO:0045722) |
| 0.2 |
2.8 |
GO:0009250 |
glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
| 0.2 |
0.8 |
GO:0006768 |
biotin metabolic process(GO:0006768) |
| 0.2 |
0.2 |
GO:0090400 |
stress-induced premature senescence(GO:0090400) |
| 0.2 |
1.5 |
GO:0009437 |
carnitine metabolic process(GO:0009437) |
| 0.2 |
3.5 |
GO:0045663 |
positive regulation of myoblast differentiation(GO:0045663) |
| 0.2 |
2.2 |
GO:0008635 |
activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
| 0.2 |
0.6 |
GO:0051712 |
positive regulation of killing of cells of other organism(GO:0051712) |
| 0.2 |
1.0 |
GO:0060437 |
lung growth(GO:0060437) |
| 0.2 |
0.6 |
GO:0036071 |
N-glycan fucosylation(GO:0036071) |
| 0.2 |
0.9 |
GO:0071360 |
cellular response to exogenous dsRNA(GO:0071360) |
| 0.2 |
0.3 |
GO:0035262 |
gonad morphogenesis(GO:0035262) |
| 0.2 |
2.7 |
GO:0030206 |
chondroitin sulfate biosynthetic process(GO:0030206) |
| 0.2 |
0.8 |
GO:0021904 |
dorsal/ventral neural tube patterning(GO:0021904) |
| 0.2 |
2.2 |
GO:0009070 |
serine family amino acid biosynthetic process(GO:0009070) |
| 0.2 |
0.3 |
GO:1901857 |
positive regulation of cellular respiration(GO:1901857) |
| 0.2 |
1.6 |
GO:0060907 |
positive regulation of macrophage cytokine production(GO:0060907) |
| 0.2 |
0.5 |
GO:1904586 |
response to putrescine(GO:1904585) cellular response to putrescine(GO:1904586) hepatocyte dedifferentiation(GO:1990828) |
| 0.2 |
0.5 |
GO:0021859 |
pyramidal neuron differentiation(GO:0021859) |
| 0.2 |
0.6 |
GO:0010430 |
fatty acid omega-oxidation(GO:0010430) |
| 0.2 |
0.6 |
GO:0046007 |
negative regulation of activated T cell proliferation(GO:0046007) |
| 0.2 |
0.3 |
GO:2000563 |
positive regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000563) |
| 0.2 |
0.8 |
GO:1903608 |
protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.2 |
0.5 |
GO:0001773 |
myeloid dendritic cell activation(GO:0001773) |
| 0.2 |
1.7 |
GO:0070914 |
UV-damage excision repair(GO:0070914) |
| 0.2 |
0.6 |
GO:0044376 |
RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 0.1 |
9.0 |
GO:0000186 |
activation of MAPKK activity(GO:0000186) |
| 0.1 |
1.3 |
GO:0015909 |
long-chain fatty acid transport(GO:0015909) |
| 0.1 |
0.3 |
GO:0009446 |
putrescine biosynthetic process(GO:0009446) |
| 0.1 |
0.7 |
GO:0007494 |
midgut development(GO:0007494) |
| 0.1 |
2.1 |
GO:0032957 |
inositol trisphosphate metabolic process(GO:0032957) |
| 0.1 |
1.6 |
GO:0042074 |
cell migration involved in gastrulation(GO:0042074) |
| 0.1 |
2.2 |
GO:0051231 |
spindle elongation(GO:0051231) |
| 0.1 |
3.7 |
GO:0048566 |
embryonic digestive tract development(GO:0048566) |
| 0.1 |
0.4 |
GO:0060467 |
negative regulation of fertilization(GO:0060467) |
| 0.1 |
1.0 |
GO:0032727 |
positive regulation of interferon-alpha production(GO:0032727) |
| 0.1 |
6.1 |
GO:0007271 |
synaptic transmission, cholinergic(GO:0007271) |
| 0.1 |
0.4 |
GO:0061643 |
chemorepulsion of axon(GO:0061643) |
| 0.1 |
0.4 |
GO:0048714 |
positive regulation of oligodendrocyte differentiation(GO:0048714) |
| 0.1 |
2.7 |
GO:0030214 |
hyaluronan catabolic process(GO:0030214) |
| 0.1 |
1.1 |
GO:0032688 |
negative regulation of interferon-beta production(GO:0032688) |
| 0.1 |
0.1 |
GO:0098908 |
regulation of neuronal action potential(GO:0098908) |
| 0.1 |
0.9 |
GO:0048742 |
regulation of skeletal muscle fiber development(GO:0048742) |
| 0.1 |
9.3 |
GO:0071277 |
cellular response to calcium ion(GO:0071277) |
| 0.1 |
0.8 |
GO:2000661 |
positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
| 0.1 |
0.4 |
GO:0007442 |
hindgut morphogenesis(GO:0007442) |
| 0.1 |
3.8 |
GO:0019835 |
cytolysis(GO:0019835) |
| 0.1 |
2.8 |
GO:0002115 |
store-operated calcium entry(GO:0002115) |
| 0.1 |
0.4 |
GO:0045415 |
negative regulation of interleukin-8 biosynthetic process(GO:0045415) |
| 0.1 |
2.2 |
GO:0006465 |
signal peptide processing(GO:0006465) |
| 0.1 |
1.5 |
GO:0034116 |
positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
| 0.1 |
0.7 |
GO:1903750 |
regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
| 0.1 |
0.4 |
GO:0032516 |
positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
| 0.1 |
0.3 |
GO:0019085 |
early viral transcription(GO:0019085) |
| 0.1 |
1.3 |
GO:0010165 |
response to X-ray(GO:0010165) |
| 0.1 |
1.7 |
GO:1902083 |
negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
| 0.1 |
0.5 |
GO:0033197 |
response to vitamin E(GO:0033197) |
| 0.1 |
0.3 |
GO:0034104 |
negative regulation of tissue remodeling(GO:0034104) negative regulation of bone resorption(GO:0045779) negative regulation of bone remodeling(GO:0046851) |
| 0.1 |
0.8 |
GO:0043403 |
skeletal muscle tissue regeneration(GO:0043403) |
| 0.1 |
3.0 |
GO:0006505 |
GPI anchor metabolic process(GO:0006505) GPI anchor biosynthetic process(GO:0006506) |
| 0.1 |
0.8 |
GO:0099500 |
synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
| 0.1 |
0.3 |
GO:2001274 |
negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
| 0.1 |
0.8 |
GO:0034214 |
protein hexamerization(GO:0034214) |
| 0.1 |
0.5 |
GO:0051084 |
'de novo' posttranslational protein folding(GO:0051084) |
| 0.1 |
1.9 |
GO:0046501 |
protoporphyrinogen IX metabolic process(GO:0046501) |
| 0.1 |
1.4 |
GO:0006012 |
galactose metabolic process(GO:0006012) |
| 0.1 |
0.8 |
GO:0030422 |
production of siRNA involved in RNA interference(GO:0030422) |
| 0.1 |
0.1 |
GO:0009438 |
methylglyoxal metabolic process(GO:0009438) |
| 0.1 |
1.0 |
GO:0098989 |
NMDA selective glutamate receptor signaling pathway(GO:0098989) |
| 0.1 |
0.5 |
GO:0030952 |
establishment or maintenance of cytoskeleton polarity(GO:0030952) |
| 0.1 |
9.4 |
GO:0019395 |
fatty acid oxidation(GO:0019395) |
| 0.1 |
1.9 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.1 |
3.0 |
GO:0070262 |
peptidyl-serine dephosphorylation(GO:0070262) |
| 0.1 |
0.4 |
GO:0033319 |
UDP-D-xylose metabolic process(GO:0033319) UDP-D-xylose biosynthetic process(GO:0033320) |
| 0.1 |
0.2 |
GO:0043092 |
L-amino acid import(GO:0043092) |
| 0.1 |
0.9 |
GO:0060068 |
vagina development(GO:0060068) |
| 0.1 |
0.1 |
GO:0035562 |
negative regulation of chromatin binding(GO:0035562) |
| 0.1 |
0.1 |
GO:0038183 |
bile acid signaling pathway(GO:0038183) |
| 0.1 |
0.4 |
GO:0061568 |
dADP phosphorylation(GO:0006174) dGDP phosphorylation(GO:0006186) AMP phosphorylation(GO:0006756) CDP phosphorylation(GO:0061508) dAMP phosphorylation(GO:0061565) CMP phosphorylation(GO:0061566) dCMP phosphorylation(GO:0061567) GDP phosphorylation(GO:0061568) UDP phosphorylation(GO:0061569) dCDP phosphorylation(GO:0061570) TDP phosphorylation(GO:0061571) |
| 0.1 |
0.9 |
GO:0016129 |
phytosteroid metabolic process(GO:0016128) phytosteroid biosynthetic process(GO:0016129) |
| 0.1 |
0.1 |
GO:1990009 |
retinal cell apoptotic process(GO:1990009) |
| 0.1 |
0.2 |
GO:1904849 |
positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
| 0.1 |
1.1 |
GO:0031087 |
deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.1 |
1.8 |
GO:2000615 |
regulation of histone H3-K9 acetylation(GO:2000615) |
| 0.1 |
0.1 |
GO:0071313 |
cellular response to caffeine(GO:0071313) |
| 0.1 |
1.4 |
GO:0046475 |
glycerophospholipid catabolic process(GO:0046475) |
| 0.1 |
0.5 |
GO:0046900 |
tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 0.1 |
1.5 |
GO:0061303 |
cornea development in camera-type eye(GO:0061303) |
| 0.1 |
0.7 |
GO:0001915 |
negative regulation of T cell mediated cytotoxicity(GO:0001915) |
| 0.1 |
0.6 |
GO:0034501 |
protein localization to kinetochore(GO:0034501) |
| 0.1 |
1.1 |
GO:0018298 |
protein-chromophore linkage(GO:0018298) |
| 0.1 |
0.8 |
GO:0072348 |
sulfur compound transport(GO:0072348) |
| 0.1 |
0.3 |
GO:1900275 |
negative regulation of phospholipase C activity(GO:1900275) |
| 0.1 |
0.6 |
GO:0032785 |
negative regulation of DNA-templated transcription, elongation(GO:0032785) |
| 0.1 |
0.9 |
GO:0032485 |
Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
| 0.1 |
0.6 |
GO:0072567 |
chemokine (C-X-C motif) ligand 2 production(GO:0072567) |
| 0.1 |
1.8 |
GO:0050995 |
negative regulation of lipid catabolic process(GO:0050995) |
| 0.1 |
1.1 |
GO:0048009 |
insulin-like growth factor receptor signaling pathway(GO:0048009) |
| 0.1 |
0.1 |
GO:1902232 |
regulation of positive thymic T cell selection(GO:1902232) |
| 0.1 |
0.2 |
GO:0032825 |
positive regulation of natural killer cell differentiation(GO:0032825) |
| 0.1 |
2.6 |
GO:0090140 |
regulation of mitochondrial fission(GO:0090140) |
| 0.1 |
0.7 |
GO:2000786 |
positive regulation of autophagosome assembly(GO:2000786) |
| 0.1 |
0.2 |
GO:0022010 |
central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
| 0.1 |
0.1 |
GO:0043652 |
engulfment of apoptotic cell(GO:0043652) |
| 0.1 |
0.8 |
GO:1900383 |
regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.1 |
1.8 |
GO:0007091 |
metaphase/anaphase transition of mitotic cell cycle(GO:0007091) metaphase/anaphase transition of cell cycle(GO:0044784) |
| 0.1 |
14.8 |
GO:0071466 |
cellular response to xenobiotic stimulus(GO:0071466) |
| 0.1 |
0.3 |
GO:0051788 |
response to misfolded protein(GO:0051788) |
| 0.1 |
0.3 |
GO:0032815 |
negative regulation of natural killer cell activation(GO:0032815) |
| 0.1 |
0.2 |
GO:0046532 |
regulation of photoreceptor cell differentiation(GO:0046532) |
| 0.1 |
0.5 |
GO:2000253 |
positive regulation of feeding behavior(GO:2000253) |
| 0.1 |
0.1 |
GO:1903800 |
positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
| 0.1 |
0.1 |
GO:2000354 |
regulation of ovarian follicle development(GO:2000354) |
| 0.1 |
0.4 |
GO:0001806 |
type IV hypersensitivity(GO:0001806) |
| 0.1 |
1.4 |
GO:0071392 |
cellular response to estradiol stimulus(GO:0071392) |
| 0.1 |
0.1 |
GO:1901159 |
glucuronate catabolic process(GO:0006064) glucuronate catabolic process to xylulose 5-phosphate(GO:0019640) xylulose 5-phosphate metabolic process(GO:0051167) xylulose 5-phosphate biosynthetic process(GO:1901159) |
| 0.1 |
0.3 |
GO:0030187 |
melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
| 0.1 |
1.5 |
GO:0002924 |
negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
| 0.1 |
0.1 |
GO:0034144 |
negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
| 0.1 |
0.7 |
GO:0071461 |
cellular response to redox state(GO:0071461) |
| 0.1 |
0.3 |
GO:0009410 |
response to xenobiotic stimulus(GO:0009410) |
| 0.1 |
0.7 |
GO:0019585 |
uronic acid metabolic process(GO:0006063) glucuronate metabolic process(GO:0019585) cellular glucuronidation(GO:0052695) |
| 0.1 |
1.2 |
GO:0033139 |
regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033139) positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
| 0.1 |
0.3 |
GO:0044725 |
chromatin reprogramming in the zygote(GO:0044725) DNA demethylation of male pronucleus(GO:0044727) |
| 0.1 |
0.4 |
GO:1901624 |
negative regulation of lymphocyte chemotaxis(GO:1901624) |
| 0.1 |
0.2 |
GO:0070318 |
positive regulation of G0 to G1 transition(GO:0070318) |
| 0.1 |
3.2 |
GO:0015721 |
bile acid and bile salt transport(GO:0015721) |
| 0.1 |
1.3 |
GO:0034497 |
protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.1 |
2.4 |
GO:0045599 |
negative regulation of fat cell differentiation(GO:0045599) |
| 0.1 |
0.6 |
GO:0090073 |
positive regulation of protein homodimerization activity(GO:0090073) |
| 0.1 |
0.8 |
GO:0038165 |
oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.1 |
0.5 |
GO:0032026 |
response to magnesium ion(GO:0032026) |
| 0.1 |
0.5 |
GO:0015846 |
polyamine transport(GO:0015846) |
| 0.1 |
0.2 |
GO:0044806 |
G-quadruplex DNA unwinding(GO:0044806) |
| 0.1 |
5.2 |
GO:0030433 |
ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
| 0.1 |
3.0 |
GO:0046856 |
phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.1 |
1.1 |
GO:0033198 |
response to ATP(GO:0033198) |
| 0.1 |
1.2 |
GO:0050908 |
detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.1 |
0.9 |
GO:0042407 |
cristae formation(GO:0042407) |
| 0.1 |
0.1 |
GO:0090201 |
negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
| 0.1 |
0.3 |
GO:1904526 |
regulation of microtubule binding(GO:1904526) |
| 0.1 |
0.3 |
GO:0060620 |
regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
| 0.1 |
0.2 |
GO:0002581 |
negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
| 0.1 |
0.2 |
GO:0051024 |
positive regulation of immunoglobulin secretion(GO:0051024) |
| 0.1 |
0.3 |
GO:0035674 |
tricarboxylic acid transmembrane transport(GO:0035674) |
| 0.1 |
0.1 |
GO:0044256 |
angiotensin catabolic process in blood(GO:0002005) multicellular organismal protein catabolic process(GO:0044254) protein digestion(GO:0044256) multicellular organismal macromolecule catabolic process(GO:0044266) |
| 0.1 |
3.3 |
GO:0031146 |
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.1 |
0.1 |
GO:0022401 |
desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) adaptation of signaling pathway(GO:0023058) |
| 0.1 |
0.3 |
GO:0033046 |
negative regulation of sister chromatid segregation(GO:0033046) negative regulation of chromosome segregation(GO:0051985) |
| 0.1 |
0.3 |
GO:0036496 |
regulation of translational initiation by eIF2 alpha dephosphorylation(GO:0036496) |
| 0.1 |
0.2 |
GO:0006681 |
galactosylceramide metabolic process(GO:0006681) galactolipid metabolic process(GO:0019374) |
| 0.1 |
0.3 |
GO:0021997 |
neural plate axis specification(GO:0021997) |
| 0.1 |
0.2 |
GO:0071799 |
response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
| 0.1 |
0.3 |
GO:0001180 |
transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
| 0.1 |
3.1 |
GO:0018345 |
protein palmitoylation(GO:0018345) |
| 0.1 |
0.8 |
GO:0021591 |
ventricular system development(GO:0021591) |
| 0.1 |
1.4 |
GO:0033260 |
nuclear DNA replication(GO:0033260) |
| 0.1 |
0.2 |
GO:0043335 |
protein unfolding(GO:0043335) |
| 0.1 |
0.9 |
GO:0060700 |
regulation of ribonuclease activity(GO:0060700) |
| 0.1 |
0.1 |
GO:0021943 |
formation of radial glial scaffolds(GO:0021943) |
| 0.1 |
0.5 |
GO:0060732 |
positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
| 0.1 |
0.7 |
GO:0006398 |
mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.1 |
0.2 |
GO:0046689 |
response to mercury ion(GO:0046689) |
| 0.1 |
1.1 |
GO:0060079 |
excitatory postsynaptic potential(GO:0060079) |
| 0.1 |
0.8 |
GO:0042311 |
vasodilation(GO:0042311) |
| 0.1 |
0.3 |
GO:0021831 |
embryonic olfactory bulb interneuron precursor migration(GO:0021831) |
| 0.1 |
0.5 |
GO:0052551 |
response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
| 0.1 |
0.3 |
GO:2001245 |
regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
| 0.1 |
2.9 |
GO:0061512 |
protein localization to cilium(GO:0061512) |
| 0.1 |
0.4 |
GO:0010735 |
positive regulation of transcription via serum response element binding(GO:0010735) |
| 0.1 |
0.3 |
GO:0008228 |
opsonization(GO:0008228) |
| 0.1 |
0.4 |
GO:0002036 |
regulation of L-glutamate transport(GO:0002036) |
| 0.1 |
0.3 |
GO:0046826 |
negative regulation of protein export from nucleus(GO:0046826) |
| 0.1 |
0.3 |
GO:0000729 |
DNA double-strand break processing(GO:0000729) |
| 0.1 |
0.2 |
GO:0099590 |
neurotransmitter receptor internalization(GO:0099590) |
| 0.1 |
0.3 |
GO:0003351 |
epithelial cilium movement(GO:0003351) |
| 0.1 |
0.9 |
GO:0045023 |
G0 to G1 transition(GO:0045023) |
| 0.1 |
1.2 |
GO:0050848 |
regulation of calcium-mediated signaling(GO:0050848) |
| 0.1 |
0.2 |
GO:0044028 |
DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
| 0.1 |
0.9 |
GO:0014819 |
regulation of skeletal muscle contraction(GO:0014819) |
| 0.1 |
0.3 |
GO:0017004 |
cytochrome complex assembly(GO:0017004) |
| 0.1 |
0.5 |
GO:0019355 |
nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.1 |
0.2 |
GO:0034315 |
regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
| 0.1 |
0.5 |
GO:0043201 |
response to leucine(GO:0043201) |
| 0.1 |
0.2 |
GO:1904469 |
positive regulation of tumor necrosis factor secretion(GO:1904469) |
| 0.1 |
0.4 |
GO:0006983 |
ER overload response(GO:0006983) |
| 0.1 |
0.2 |
GO:0090521 |
glomerular visceral epithelial cell migration(GO:0090521) |
| 0.1 |
0.2 |
GO:0000349 |
generation of catalytic spliceosome for first transesterification step(GO:0000349) |
| 0.1 |
0.2 |
GO:0007501 |
mesodermal cell fate specification(GO:0007501) |
| 0.1 |
0.2 |
GO:0050912 |
detection of chemical stimulus involved in sensory perception of taste(GO:0050912) |
| 0.1 |
2.3 |
GO:1902475 |
L-alpha-amino acid transmembrane transport(GO:1902475) |
| 0.1 |
0.4 |
GO:0006516 |
glycoprotein catabolic process(GO:0006516) |
| 0.1 |
0.4 |
GO:0051589 |
negative regulation of neurotransmitter transport(GO:0051589) |
| 0.1 |
1.4 |
GO:0007520 |
myoblast fusion(GO:0007520) |
| 0.1 |
2.1 |
GO:0015991 |
ATP hydrolysis coupled proton transport(GO:0015991) |
| 0.1 |
0.4 |
GO:0014870 |
response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to stimulus involved in regulation of muscle adaptation(GO:0014874) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 0.1 |
0.1 |
GO:0010807 |
regulation of synaptic vesicle priming(GO:0010807) |
| 0.1 |
0.6 |
GO:0036444 |
calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 0.1 |
1.2 |
GO:1904380 |
endoplasmic reticulum mannose trimming(GO:1904380) |
| 0.1 |
0.4 |
GO:1904970 |
brush border assembly(GO:1904970) |
| 0.1 |
0.5 |
GO:0030502 |
negative regulation of bone mineralization(GO:0030502) |
| 0.1 |
0.3 |
GO:0010172 |
embryonic body morphogenesis(GO:0010172) |
| 0.1 |
0.1 |
GO:0008272 |
sulfate transport(GO:0008272) |
| 0.1 |
0.5 |
GO:0030002 |
cellular anion homeostasis(GO:0030002) cellular monovalent inorganic anion homeostasis(GO:0030320) |
| 0.1 |
0.1 |
GO:0006826 |
iron ion transport(GO:0006826) |
| 0.1 |
0.3 |
GO:0015868 |
purine ribonucleotide transport(GO:0015868) |
| 0.1 |
0.8 |
GO:0000290 |
deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.1 |
0.1 |
GO:0038171 |
cannabinoid signaling pathway(GO:0038171) |
| 0.1 |
0.2 |
GO:0014898 |
muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
| 0.1 |
0.2 |
GO:0006145 |
purine nucleobase catabolic process(GO:0006145) |
| 0.1 |
1.5 |
GO:0060338 |
regulation of type I interferon-mediated signaling pathway(GO:0060338) |
| 0.1 |
0.8 |
GO:0035994 |
response to muscle stretch(GO:0035994) |
| 0.1 |
0.7 |
GO:0006828 |
manganese ion transport(GO:0006828) |
| 0.1 |
0.1 |
GO:0048745 |
smooth muscle tissue development(GO:0048745) |
| 0.1 |
0.1 |
GO:0016576 |
histone dephosphorylation(GO:0016576) |
| 0.1 |
0.6 |
GO:0070294 |
renal sodium ion absorption(GO:0070294) |
| 0.1 |
0.3 |
GO:0097052 |
L-kynurenine metabolic process(GO:0097052) |
| 0.1 |
0.1 |
GO:0090383 |
phagosome acidification(GO:0090383) |
| 0.1 |
0.7 |
GO:0035999 |
tetrahydrofolate interconversion(GO:0035999) |
| 0.1 |
0.1 |
GO:0003104 |
positive regulation of glomerular filtration(GO:0003104) |
| 0.1 |
0.1 |
GO:0002820 |
negative regulation of adaptive immune response(GO:0002820) |
| 0.1 |
0.6 |
GO:0010265 |
SCF complex assembly(GO:0010265) |
| 0.1 |
0.1 |
GO:0090107 |
regulation of high-density lipoprotein particle assembly(GO:0090107) |
| 0.1 |
0.6 |
GO:0002291 |
T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
| 0.1 |
0.6 |
GO:0007597 |
blood coagulation, intrinsic pathway(GO:0007597) |
| 0.1 |
0.1 |
GO:0030101 |
natural killer cell activation(GO:0030101) |
| 0.1 |
0.2 |
GO:2000628 |
regulation of miRNA metabolic process(GO:2000628) |
| 0.1 |
0.1 |
GO:1902564 |
regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) negative regulation of neutrophil activation(GO:1902564) regulation of eosinophil activation(GO:1902566) |
| 0.1 |
0.3 |
GO:0035694 |
mitochondrial protein catabolic process(GO:0035694) |
| 0.1 |
0.7 |
GO:0051156 |
glucose 6-phosphate metabolic process(GO:0051156) |
| 0.1 |
1.6 |
GO:0006895 |
Golgi to endosome transport(GO:0006895) |
| 0.1 |
0.2 |
GO:0006421 |
asparaginyl-tRNA aminoacylation(GO:0006421) |
| 0.1 |
0.1 |
GO:0033563 |
dorsal/ventral axon guidance(GO:0033563) |
| 0.1 |
0.6 |
GO:0006089 |
lactate metabolic process(GO:0006089) |
| 0.1 |
0.2 |
GO:0042088 |
T-helper 1 type immune response(GO:0042088) |
| 0.1 |
0.1 |
GO:0021871 |
forebrain regionalization(GO:0021871) |
| 0.1 |
0.2 |
GO:0090671 |
RNA localization to Cajal body(GO:0090670) telomerase RNA localization to Cajal body(GO:0090671) telomerase RNA localization(GO:0090672) |
| 0.1 |
0.5 |
GO:0032328 |
alanine transport(GO:0032328) |
| 0.1 |
0.3 |
GO:0000056 |
ribosomal small subunit export from nucleus(GO:0000056) |
| 0.1 |
1.1 |
GO:0035025 |
positive regulation of Rho protein signal transduction(GO:0035025) |
| 0.1 |
0.8 |
GO:0046085 |
adenosine metabolic process(GO:0046085) |
| 0.1 |
0.2 |
GO:0002503 |
peptide antigen assembly with MHC class II protein complex(GO:0002503) |
| 0.1 |
0.5 |
GO:0001556 |
oocyte maturation(GO:0001556) |
| 0.1 |
0.1 |
GO:0035881 |
amacrine cell differentiation(GO:0035881) |
| 0.1 |
1.0 |
GO:0031468 |
nuclear envelope reassembly(GO:0031468) |
| 0.1 |
0.2 |
GO:0006384 |
transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.1 |
0.4 |
GO:0044387 |
negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
| 0.1 |
0.3 |
GO:0048484 |
enteric nervous system development(GO:0048484) |
| 0.1 |
0.2 |
GO:0003310 |
pancreatic A cell differentiation(GO:0003310) |
| 0.1 |
0.1 |
GO:0043461 |
proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
| 0.1 |
0.4 |
GO:0016048 |
detection of temperature stimulus(GO:0016048) |
| 0.1 |
1.0 |
GO:0019228 |
neuronal action potential(GO:0019228) |
| 0.1 |
0.7 |
GO:0007258 |
JUN phosphorylation(GO:0007258) |
| 0.1 |
1.2 |
GO:0007131 |
reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
| 0.1 |
0.7 |
GO:0010569 |
regulation of double-strand break repair via homologous recombination(GO:0010569) |
| 0.1 |
1.4 |
GO:0072698 |
protein localization to microtubule cytoskeleton(GO:0072698) |
| 0.1 |
0.4 |
GO:2000427 |
positive regulation of apoptotic cell clearance(GO:2000427) |
| 0.0 |
2.3 |
GO:0006362 |
transcription elongation from RNA polymerase I promoter(GO:0006362) |
| 0.0 |
0.4 |
GO:0045039 |
protein import into mitochondrial inner membrane(GO:0045039) |
| 0.0 |
0.0 |
GO:0007468 |
regulation of rhodopsin gene expression(GO:0007468) |
| 0.0 |
0.4 |
GO:0018094 |
protein polyglycylation(GO:0018094) |
| 0.0 |
0.4 |
GO:0016127 |
cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.0 |
0.4 |
GO:0006284 |
base-excision repair(GO:0006284) |
| 0.0 |
0.7 |
GO:0043402 |
glucocorticoid mediated signaling pathway(GO:0043402) |
| 0.0 |
0.7 |
GO:0071816 |
tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
| 0.0 |
0.6 |
GO:0043486 |
histone exchange(GO:0043486) |
| 0.0 |
0.2 |
GO:2000535 |
regulation of entry of bacterium into host cell(GO:2000535) |
| 0.0 |
0.1 |
GO:0045204 |
MAPK export from nucleus(GO:0045204) |
| 0.0 |
0.1 |
GO:0097107 |
postsynaptic density assembly(GO:0097107) |
| 0.0 |
0.6 |
GO:0005513 |
detection of calcium ion(GO:0005513) |
| 0.0 |
0.1 |
GO:2000508 |
regulation of dendritic cell chemotaxis(GO:2000508) positive regulation of dendritic cell chemotaxis(GO:2000510) |
| 0.0 |
0.4 |
GO:0097338 |
response to clozapine(GO:0097338) |
| 0.0 |
0.2 |
GO:0007263 |
nitric oxide mediated signal transduction(GO:0007263) |
| 0.0 |
0.2 |
GO:0006102 |
isocitrate metabolic process(GO:0006102) |
| 0.0 |
0.1 |
GO:1903980 |
positive regulation of microglial cell activation(GO:1903980) |
| 0.0 |
0.2 |
GO:0018002 |
N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.0 |
0.2 |
GO:0042092 |
type 2 immune response(GO:0042092) |
| 0.0 |
0.1 |
GO:0045047 |
protein targeting to ER(GO:0045047) |
| 0.0 |
0.1 |
GO:0070544 |
histone H3-K36 demethylation(GO:0070544) |
| 0.0 |
0.2 |
GO:0048245 |
eosinophil chemotaxis(GO:0048245) |
| 0.0 |
0.0 |
GO:0010936 |
negative regulation of macrophage cytokine production(GO:0010936) |
| 0.0 |
0.3 |
GO:0032914 |
positive regulation of transforming growth factor beta1 production(GO:0032914) |
| 0.0 |
0.3 |
GO:0045475 |
locomotor rhythm(GO:0045475) |
| 0.0 |
0.2 |
GO:0048539 |
bone marrow development(GO:0048539) |
| 0.0 |
0.1 |
GO:0042414 |
epinephrine metabolic process(GO:0042414) epinephrine biosynthetic process(GO:0042418) |
| 0.0 |
1.3 |
GO:0042590 |
antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
| 0.0 |
1.1 |
GO:0090502 |
RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
| 0.0 |
0.0 |
GO:0016240 |
autophagosome docking(GO:0016240) |
| 0.0 |
0.2 |
GO:0090230 |
regulation of centromere complex assembly(GO:0090230) regulation of kinetochore assembly(GO:0090234) |
| 0.0 |
0.1 |
GO:1902563 |
regulation of neutrophil degranulation(GO:0043313) regulation of neutrophil activation(GO:1902563) |
| 0.0 |
0.2 |
GO:0035608 |
protein deglutamylation(GO:0035608) |
| 0.0 |
0.1 |
GO:0060040 |
retinal bipolar neuron differentiation(GO:0060040) |
| 0.0 |
0.4 |
GO:0071391 |
cellular response to estrogen stimulus(GO:0071391) |
| 0.0 |
0.1 |
GO:0045623 |
negative regulation of CD4-positive, alpha-beta T cell differentiation(GO:0043371) negative regulation of T-helper cell differentiation(GO:0045623) negative regulation of alpha-beta T cell differentiation(GO:0046639) |
| 0.0 |
0.0 |
GO:1990785 |
response to water-immersion restraint stress(GO:1990785) |
| 0.0 |
0.1 |
GO:0097112 |
gamma-aminobutyric acid receptor clustering(GO:0097112) |
| 0.0 |
0.1 |
GO:0048149 |
behavioral response to ethanol(GO:0048149) |
| 0.0 |
2.4 |
GO:0051965 |
positive regulation of synapse assembly(GO:0051965) |
| 0.0 |
0.1 |
GO:0019046 |
release from viral latency(GO:0019046) |
| 0.0 |
0.2 |
GO:0070124 |
mitochondrial translational initiation(GO:0070124) |
| 0.0 |
0.1 |
GO:0051386 |
regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
| 0.0 |
0.1 |
GO:0007217 |
tachykinin receptor signaling pathway(GO:0007217) |
| 0.0 |
0.1 |
GO:0001694 |
histamine biosynthetic process(GO:0001694) |
| 0.0 |
0.1 |
GO:0002318 |
myeloid progenitor cell differentiation(GO:0002318) |
| 0.0 |
0.2 |
GO:0051083 |
'de novo' cotranslational protein folding(GO:0051083) |
| 0.0 |
0.1 |
GO:0032790 |
ribosome disassembly(GO:0032790) |
| 0.0 |
0.1 |
GO:0043654 |
recognition of apoptotic cell(GO:0043654) |
| 0.0 |
0.1 |
GO:0030037 |
actin filament reorganization involved in cell cycle(GO:0030037) |
| 0.0 |
0.2 |
GO:0050850 |
positive regulation of calcium-mediated signaling(GO:0050850) |
| 0.0 |
0.2 |
GO:0021615 |
glossopharyngeal nerve morphogenesis(GO:0021615) |
| 0.0 |
0.2 |
GO:0043984 |
histone H4-K16 acetylation(GO:0043984) |
| 0.0 |
0.4 |
GO:0044364 |
killing of cells of other organism(GO:0031640) disruption of cells of other organism(GO:0044364) |
| 0.0 |
0.1 |
GO:2000479 |
regulation of cAMP-dependent protein kinase activity(GO:2000479) |
| 0.0 |
0.1 |
GO:0031665 |
negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
| 0.0 |
0.0 |
GO:0032275 |
luteinizing hormone secretion(GO:0032275) |
| 0.0 |
0.5 |
GO:0045746 |
negative regulation of Notch signaling pathway(GO:0045746) |
| 0.0 |
0.1 |
GO:0030505 |
inorganic diphosphate transport(GO:0030505) |
| 0.0 |
0.1 |
GO:0060837 |
blood vessel endothelial cell differentiation(GO:0060837) |
| 0.0 |
0.1 |
GO:0033206 |
meiotic cytokinesis(GO:0033206) |
| 0.0 |
0.4 |
GO:0048935 |
peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
| 0.0 |
1.2 |
GO:0055072 |
iron ion homeostasis(GO:0055072) |
| 0.0 |
0.1 |
GO:0002026 |
regulation of the force of heart contraction(GO:0002026) |
| 0.0 |
0.0 |
GO:0002862 |
negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
| 0.0 |
0.5 |
GO:0050855 |
regulation of B cell receptor signaling pathway(GO:0050855) |
| 0.0 |
0.0 |
GO:0008588 |
release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
| 0.0 |
0.3 |
GO:2000601 |
positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 0.0 |
0.0 |
GO:0016074 |
snoRNA metabolic process(GO:0016074) snoRNA processing(GO:0043144) |
| 0.0 |
0.1 |
GO:1904158 |
axonemal central apparatus assembly(GO:1904158) |
| 0.0 |
0.0 |
GO:0038170 |
somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
| 0.0 |
0.1 |
GO:0050993 |
dimethylallyl diphosphate biosynthetic process(GO:0050992) dimethylallyl diphosphate metabolic process(GO:0050993) |
| 0.0 |
0.2 |
GO:0090286 |
cytoskeletal anchoring at nuclear membrane(GO:0090286) |
| 0.0 |
0.1 |
GO:0038112 |
interleukin-8-mediated signaling pathway(GO:0038112) |
| 0.0 |
0.0 |
GO:0009957 |
epidermal cell fate specification(GO:0009957) |
| 0.0 |
0.2 |
GO:2000210 |
positive regulation of anoikis(GO:2000210) |
| 0.0 |
0.1 |
GO:0046603 |
negative regulation of mitotic centrosome separation(GO:0046603) |
| 0.0 |
0.4 |
GO:1902307 |
positive regulation of sodium ion transmembrane transport(GO:1902307) positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
| 0.0 |
0.1 |
GO:0003418 |
growth plate cartilage chondrocyte differentiation(GO:0003418) |
| 0.0 |
0.1 |
GO:0090051 |
negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
| 0.0 |
0.0 |
GO:0020027 |
hemoglobin metabolic process(GO:0020027) |
| 0.0 |
0.2 |
GO:0006265 |
DNA topological change(GO:0006265) |
| 0.0 |
0.1 |
GO:0021910 |
smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021910) |
| 0.0 |
2.2 |
GO:0006613 |
cotranslational protein targeting to membrane(GO:0006613) |
| 0.0 |
0.2 |
GO:0072513 |
positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
| 0.0 |
0.1 |
GO:0006702 |
androgen biosynthetic process(GO:0006702) |
| 0.0 |
0.0 |
GO:0006563 |
L-serine metabolic process(GO:0006563) |
| 0.0 |
0.1 |
GO:0030207 |
chondroitin sulfate catabolic process(GO:0030207) |
| 0.0 |
0.1 |
GO:0044245 |
polysaccharide digestion(GO:0044245) |
| 0.0 |
0.0 |
GO:0090149 |
mitochondrial membrane fission(GO:0090149) |
| 0.0 |
0.0 |
GO:0046641 |
positive regulation of alpha-beta T cell proliferation(GO:0046641) |
| 0.0 |
0.1 |
GO:0050764 |
regulation of phagocytosis(GO:0050764) |
| 0.0 |
0.0 |
GO:0006710 |
androgen catabolic process(GO:0006710) |
| 0.0 |
0.0 |
GO:0036148 |
phosphatidylglycerol acyl-chain remodeling(GO:0036148) |
| 0.0 |
0.1 |
GO:0010890 |
positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.0 |
0.1 |
GO:0035414 |
negative regulation of catenin import into nucleus(GO:0035414) |
| 0.0 |
0.0 |
GO:0035457 |
cellular response to interferon-alpha(GO:0035457) |
| 0.0 |
0.0 |
GO:0045835 |
negative regulation of meiotic nuclear division(GO:0045835) |
| 0.0 |
0.2 |
GO:0051782 |
negative regulation of cell division(GO:0051782) |
| 0.0 |
0.1 |
GO:0038001 |
paracrine signaling(GO:0038001) |
| 0.0 |
0.1 |
GO:0071028 |
nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
| 0.0 |
0.2 |
GO:0006030 |
chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
| 0.0 |
0.0 |
GO:0032713 |
negative regulation of interleukin-4 production(GO:0032713) |
| 0.0 |
0.0 |
GO:0070445 |
oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
| 0.0 |
0.5 |
GO:0033120 |
positive regulation of RNA splicing(GO:0033120) |
| 0.0 |
0.0 |
GO:0050994 |
regulation of lipid catabolic process(GO:0050994) |
| 0.0 |
0.1 |
GO:0044803 |
multi-organism membrane organization(GO:0044803) |
| 0.0 |
0.0 |
GO:0032053 |
ciliary basal body organization(GO:0032053) |
| 0.0 |
0.0 |
GO:0000270 |
peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
